Cellebrite DI (CLBT) POS AM 30 Mar 22 Prospectus update (post-effective amendment) Financial data

Document And Entity Information

Document And Entity Information	12 Months Ended
	Dec. 31, 2021
Document Information Line Items
Entity Registrant Name	Cellebrite DI Ltd.
Document Type	POS AM
Amendment Flag	true
Amendment Description	On September 27, 2021, the registrant filed a Registration Statement on Form F-1 (Registration No. 333-259826), which was subsequently declared effective by the U.S. Securities and Exchange Commission (the “SEC”) on October 6, 2021 (“Registration Statement”).This post-effective amendment is being filed to update the Registration Statement to (i) include information contained in the registrant’s annual report on Form 20-F for the fiscal year ended December 31, 2021, filed with the SEC on March 29, 2022, and (ii) to update certain other information in such Registration Statement.No additional securities are being registered under this post-effective amendment. All applicable registration fees were paid at the time of the original filing of the Registration Statement.
Entity Central Index Key	0001854587
Document Period End Date	Dec. 31, 2021
Entity Small Business	false
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Incorporation, State or Country Code	L3

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands		Dec. 31, 2021	Dec. 31, 2020
Current assets
Cash and cash equivalents		$ 145,973	$ 128,709
Restricted cash			5,137
Short-term deposits		35,592	108,928
Trade receivables (net of allowance for doubtful accounts of $1,040 and $616 as of December 31, 2021 and December 31, 2020, respectively)		67,505	66,324
Prepaid expenses and other current assets		12,818	7,439
Contract acquisition costs		4,813	2,979
Inventories		6,511	4,754
Total current assets		273,212	324,270
Non-current assets
Other non-current assets		1,958	565
Deferred tax assets, net		9,800	7,372
Property and equipment, net		16,756	16,106
Intangible assets, net		11,228	6,611
Goodwill		26,829	9,463
Total non-current assets		66,571	40,117
Total assets		339,783	364,387
Current liabilities
Trade payables		9,546	4,727
Other accounts payable and accrued expenses		54,044	49,112
Deferred revenues		122,983	105,543
Total current liabilities		186,573	159,382
Long-term liabilities
Liability for employees’ severance benefits		375	366
Other long term liabilities		9,162	6,191
Deferred revenues		36,426	33,439
Restricted Sponsor Shares liability		44,712
Price Adjustment Shares liability		79,404
Derivative warrant liabilities		56,478
Total long-term liabilities		226,557	39,996
Total liabilities		413,130	199,378
Liens, commitments and contingencies
Redeemable convertible preferred shares, NIS 0.00001 par value; 39,779,261 shares authorized, issued and outstanding as of December 31, 2020. Aggregate liquidation preference of $134,411, as of December 31, 2020	[1]		101,205
Shareholders’ equity (deficiency)
Share capital, NIS 0.00001 par value; 3,454,112,863 shares authorized and 187,680,294 and 124,671,507 shares issued and outstanding as of December 31, 2021 and 2020, respectively	[1],[2]
Additional paid-in capital		(153,072)	34,226
Treasury stock, NIS 0.00001 par value; 43,540 ordinary shares	[1]	(85)	(85)
Accumulated other comprehensive income		1,372	1,321
Retained earnings		78,438	28,342
Total Shareholders’ equity (deficiency)		(73,347)	63,804
Total liabilities, redeemable convertible preferred shares and shareholders’ equity		$ 339,783	$ 364,387
[1]	Prior period results have been retroactively adjusted to reflect the 1:1.0422 reverse stock split effected on August 30, 2021. See also Note 12, Shareholders’ Equity, for details.
[2]	Less than US$ 1.

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parentheticals) $ in Thousands	Dec. 31, 2021USD ($)shares	Dec. 31, 2021₪ / shares	Dec. 31, 2020USD ($)shares	Dec. 31, 2020₪ / shares
Statement of Financial Position [Abstract]
Net of allowance for doubtful accounts (in Dollars) | $	$ 1,040		$ 616
Redeemable convertible preferred shares, par value (in New Shekels per share) | ₪ / shares		₪ 0.00001		₪ 0.00001
Redeemable convertible preferred shares, shares authorized	39,779,261		39,779,261
Redeemable convertible preferred shares, shares issued	39,779,261		39,779,261
Redeemable convertible preferred shares, shares outstanding	39,779,261		39,779,261
Redeemable convertible preferred shares, liquidation preference value (in Dollars) | $	$ 134,411		$ 134,411
Share capital, par value (in New Shekels per share) | ₪ / shares		0.00001		0.00001
Share capital, shares authorized	3,454,112,863		3,454,112,863
Share capital, shares issued	187,680,294		187,680,294
Share capital, shares outstanding	124,671,507		124,671,507
Treasury stock, par value (in New Shekels per share) | ₪ / shares		₪ 0.00001		₪ 0.00001
Treasury stock, ordinary shares	43,540		43,540

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Revenue:
Subscription services	$ 120,889	$ 100,614	$ 81,505
Term-license	62,428	29,131	5,142
Perpetual license and other	34,169	42,136	59,175
Professional services	28,760	23,032	26,032
Total revenue	246,246	194,913	171,854
Cost of revenue:
Subscription services	9,369	8,795	6,585
Term-license	2,299	1,709	189
Perpetual license and other	9,817	9,370	10,049
Professional services	21,072	18,005	19,000
Total cost of revenue	42,557	37,879	35,823
Gross profit	203,689	157,034	136,031
Operating expenses:
Sales and marketing	76,389	61,305	61,610
Research and development	65,541	54,377	46,573
General and administrative	47,937	32,134	29,368
Total operating expenses	189,867	147,816	137,551
Operating income (loss)	13,822	9,218	(1,520)
Financial income, net	68,483	2,179	2,935
Income before income tax expense	82,305	11,397	1,415
Income tax expense	10,909	5,616	3,291
Net income (loss)	$ 71,396	$ 5,781	$ (1,876)
Net income (loss) per share:
Basic and diluted net income (loss) per share attributable to ordinary shareholders (in Shares)	70,433	(9,344)	(10,039)
Basic net income (loss) per ordinary share (in Dollars per share)	$ 0.49	$ (0.08)	$ (0.08)
Diluted net income (loss) per ordinary share (in Dollars per share)	$ 0.44	$ (0.08)	$ (0.08)
Weighted average number of ordinary shares used in computing basic net income (loss) per share (in Shares)	144,002,394	123,696,624	121,560,817
Weighted average number of ordinary shares used in computing diluted net income (loss) per share (in Shares)	161,538,579	123,696,624	121,560,817
Other comprehensive income (loss)
Unrealized gain (loss) on hedging transactions, net of taxes of $129 and $165 for the year ended December 31, 2021 and 2020 respectively	$ (944)	$ 1,212	$ 620
Foreign currency translation adjustments	995	(695)	(25)
Total other comprehensive income, net of tax	51	517	595
Total comprehensive income (loss)	$ 71,447	$ 6,298	$ (1,281)

Consolidated Statements of Op_2

Consolidated Statements of Operations (Parentheticals) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Income Statement [Abstract]
Net of taxes	$ 129	$ 165

Statements of Changes in Shareh

Statements of Changes in Shareholders’ Equity (Deficiency) - USD ($) $ in Thousands		Redeemable convertible preferred shares	Ordinary Shares Amount		Share capital		Additional paid-in capital	Treasury stock	Comprehensive income	Retained earnings	Total
Balance at Dec. 31, 2018			$ 119,818,040	[1]			$ 12,563	$ (23,898)	$ 209	$ 80,343	$ 69,217
Balance (in Shares) at Dec. 31, 2018
Effect of adoption of revenue recognition standard (in Shares)	[1]
Balance after the adoption of revenue recognition standard as of January 1, 2019			119,818,040	[1]		[2]	12,563	(23,898)	209	84,143	73,017
Net income (loss)				[1]						(1,876)	(1,876)
Foreign currency translation adjustments				[1]					(25)		(25)
Unrealized gain on hedging transactions, net				[1]					620		620
Stock based compensation				[1]			12,759				12,759
Exercise of shares option and vested RSUs			3,664,884	[1]		[2]	141				141
Issuance of redeemable convertible preferred shares		$ 101,205		[1]
Issuance of redeemable convertible preferred shares (in Shares)		39,779,261
Dividend paid				[1]						(25,000)	(25,000)
Repurchase of ordinary shares			(283,045)	[1]		[2]		(808)			(808)
Cancellation of ordinary shares				[1]		[2]		24,706		(24,706)
Balance at Dec. 31, 2019		$ 101,205	123,199,879	[1]		[2]	25,463		804	32,561	58,828
Balance (in Shares) at Dec. 31, 2019		39,779,261
Effect of adoption of revenue recognition standard	[1]					[2]				3,800	3,800
Net income (loss)				[1]						5,781	5,781
Foreign currency translation adjustments				[1]					(695)		(695)
Unrealized gain on hedging transactions, net				[1]					1,212		1,212
Stock based compensation				[1]			7,271				7,271
Exercise of shares option and vested RSUs			1,513,404	[1]		[2]	1,492				1,492
Dividend paid										(10,000)	(10,000)
Repurchase of ordinary shares			(41,776)	[1]		[2]		(85)			(85)
Balance at Dec. 31, 2020		$ 101,205	124,671,507	[1]		[2]	34,226	(85)	1,321	28,342	63,804
Balance (in Shares) at Dec. 31, 2020		39,779,261
Net income (loss)				[1]						71,396	71,396
Foreign currency translation adjustments				[1]					995		995
Unrealized gain on hedging transactions, net				[1]					(944)		(944)
Stock based compensation				[1]			6,480				6,480
Exercise of shares option and vested RSUs			2,804,827	[1]		[2]	2,305				2,305
Dividend paid				[1]			(78,700)			(21,300)	(100,000)
Recapitalization transaction with TWC			20,424,699	[1]			(213,722)				(213,722)
Issuance costs				[1]			(4,866)				(4,866)
Conversion of preferred shares		$ (101,205)	39,779,261	[1]			101,205				101,205
Conversion of preferred shares (in Shares)		(39,779,261)
Balance at Dec. 31, 2021			$ 187,680,294	[1]			$ (153,072)	$ (85)	$ 1,372	$ 78,438	$ (73,347)
Balance (in Shares) at Dec. 31, 2021
[1]	Prior period results have been retroactively adjusted to reflect the 1:1.0422 reverse stock split effected on August 30, 2021. See also Note 12, Shareholders’ Equity, for details.
[2]	Less than US$ 1.

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Cash flows from operating activities:
Net income (loss)	$ 71,396	$ 5,781	$ (1,876)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Stock based compensation	6,480	7,271	12,759
Depreciation and amortization	7,007	5,879	4,079
Increase in deferred income taxes	(1,638)	(2,818)	(1,667)
Other		689
Revaluation of derivative warrants	(11,967)
Revaluation of Restricted Sponsor Shares and Price Adjustment Shares liabilities	(55,906)
Increase (decrease) in liability for employees’ severance benefits	10	(63)	131
Increase in trade receivables	(1,958)	(19,731)	(12,220)
Increase in deferred revenues	21,804	47,738	15,841
Decrease (increase) in prepaid expenses and other current assets	(8,304)	335	(3,141)
Increase in other non-current assets	(1,394)	(339)	(27)
Decrease (increase) in inventories	(1,798)	(693)	794
Increase (decrease) in trade payables	4,239	(1,433)	974
Increase (decrease) in other accounts payables and accrued expenses	5,107	22,449	(158)
Increase in other long-term liabilities	2,974	1,445	644
Net cash provided by operating activities	36,052	66,510	16,133
Cash flows from investing activities:
Purchases of property and equipment	(5,111)	(6,181)	(6,209)
Payment related to business combination, net of cash acquired	(20,000)	(15,046)
Purchase of intangible asset	(3,000)
Short term deposits, net	73,337	14,778	(40,513)
Net cash provided by (used in) investing activities	45,226	(6,449)	(46,722)
Cash flows from financing activities:
Repurchase of common stock		(85)	(808)
Proceeds from exercise of shares	2,305	1,492	141
Proceeds from issuance of Redeemable convertible preferred shares, net of issuance costs			101,205
Payment of dividend	(100,000)	(10,000)	(25,000)
Proceeds from Recapitalization transaction, net	29,298
Net cash provided by (used in) financing activities	(68,397)	(8,593)	75,538
Net increase in cash, cash equivalents and restricted cash	12,881	51,468	44,949
Net effect of currency translation on cash, cash equivalents and restricted cash	(754)	695	(67)
Cash, cash equivalents and restricted cash at beginning of year	133,846	81,683	36,801
Cash and cash equivalents and restricted cash at end of year	145,973	133,846	81,683
Supplemental disclosure of cash flow information:
Income taxes paid, net of refund	8,157	2,911	3,000
Supplemental disclosure of Non-cash investment activities:
Purchase of property and equipment	$ 814	$ 172	$ 263

General

General	12 Months Ended
	Dec. 31, 2021
Condensed Financial Information Disclosure [Abstract]
General	Note 1. General a. Cellebrite DI Ltd. (the “Company”), an Israeli company, was incorporated on April 13, 1999 as a private company, and began its operations in July 1999. The Company and its wholly owned subsidiaries are engaged in the development, manufacturing, marketing and selling of software and related hardware devices which allow access, unify, generate and analyze defendable digital evidence to its law enforcement customers. The Company’s primary shareholder is SUNCORPORATION, a public Company traded in the Japanese market, that creates novel ideas based on original technologies. b. On February 28, 2020, the Company completed the acquisition of 100% of the shares of BlackBag Technologies Inc. (“BlackBag”), a US computer collection and review solutions company, for the total base consideration $33,362. See also Note 3A. c. On August 30, 2021, the Company merged with TWC Tech Holdings II Corp. (“TWC”). As a result of the merger as agreed in the Merger Agreement, TWC became a direct, wholly owned subsidiary of the Company. Consequently, Cellebrite’s shares and warrants became listed on The Nasdaq Capital Market under the symbols “CLBT” and “CLBTW”, respectively. See also Note 3B. The merger is accounted as a recapitalization, with no goodwill or other intangible assets recorded, in accordance with U.S. GAAP. Under this method of accounting, Cellebrite has been determined to be the accounting acquirer. d. On November 11, 2021, the Company completed the acquisition of Digital Clues LTD. (“DC”) carved out assets, for a total consideration of $20,000. DC is an open -source e. In March 2020, the World Health Organization (”WHO”) declared the novel coronavirus COVID -19 -19 -19 -19

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 2. Summary of Significant Accounting Policies A. Basis of presentation The consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (US GAAP). The significant accounting policies followed in the preparation of the financial statements, applied on a consistent basis for all years presented in these financial statements. B. Functional Currency and Foreign Currency Translation A majority of the Company’s revenues are generated outside of Israel and are denominated in US dollars (“US$” or “dollars”). Substantial portion of materials and components cost, and marketing costs, are denominated in dollars or dollar -linked Transactions in foreign currency are translated into dollars in accordance with the principles set forth in ASC Subtopic 830 -20 Foreign Currency Transaction -monetary The effect of the translating into dollars has been included in the consolidated statements of shareholders’ equity and comprehensive income (loss) as a foreign currency translation adjustment. Gains and losses from remeasurement assets and liabilities denominated in currencies other than the respective functional currencies are included in the consolidated statements of operations. C. Use of estimates The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods and accompanying notes. Actual results could differ from those estimates. Significant items subject to such estimates and assumptions include, but are not limited to, the allocation of transaction price among various performance obligation, the fair value of acquired intangible assets and goodwill, share -based D. Principles of consolidation The accompanying consolidated financial statements include the accounts of the Company and its subsidiaries. All intercompany transactions and balances were eliminated in consolidation. E. Cash and cash equivalents and restricted cash The Company considers all highly liquid instruments with a maturity of three months or less at the date of purchase to be cash equivalents. Restricted cash consists of funds that are contractually restricted as to usage or withdrawal mainly due to a contractual agreement with an investor. The Company has presented restricted cash separately from cash and cash equivalents in the consolidated balance sheets. F. Trade Receivable Trade receivables are recorded at the invoiced amount net of allowance for doubtful accounts. The allowance for doubtful accounts is based on the Company’s assessment of in the collectability of accounts. The Company regularly reviews the adequacy of the allowance for doubtful accounts based on combination of factors, including as assessment of the current customer’s aging report, the nature and size of the customer, the financial condition of the customer and the amount of any receivables in dispute. Trade receivables deemed uncollectible are charged off against the allowance for doubtful accounts after all means of collection have been exhausted and the potential for recovery is considered remote. G. Inventories Inventories are stated at the lower of cost or net realizable value. Cost is determined by the “weighted moving average” method. Inventory write -downs Inventory write -down -cost H. Property and equipment Property and equipment are stated at cost less accumulated depreciation. Depreciation is calculated by the straight -line % Computers and software 12.5 – 33 Manufacturing equipment 7 Office furniture and equipment 7 – 15 Leasehold improvements * ___________ * Over the shorter of the expected lease term or estimated useful lives. I. Impairment of long -lived assets Long -lived Accounting for the impairment of Long -Lived Assets -lived -party -lived During the year ended December 31, 2021, 2020 and 2019, no impairment losses have been identified. J. Revenue recognition The Company’s revenues are comprised of four main categories: (a) subscription revenues, including support services (updates, upgrades and technical support) on term -based -based The Company recognizes revenue pursuant to the five -step The Company sells its products to its customers either directly or indirectly through distribution channels all of whom are considered end users. In accordance with ASC 606, revenue is recognized when a customer obtains control of promised goods or services are delivered. The amount of revenue recognized reflects the consideration that the Company expects to receive in exchange for these goods or services. The Company determines that it has a contract with a customer when each party’s rights regarding the products or services to be transferred can be identified, the payment terms for the services can be identified, the Company has determined the customer has the ability and intent to pay, and the contract has commercial substance. At contract inception, the Company evaluates whether two or more contracts should be combined and accounted for as a single contract and whether the combined or single contract includes more than one performance obligation. Performance obligations promised in a contract are identified based on the products and services that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the products or services either on their own or together with other resources that are readily available from third parties or from the Company, and are distinct in the context of the contract, whereby the transfer of the products and services is separately identifiable from other promises in the contract. The Company’s software licenses either provide its customers a perpetual right to use its software or the right to use its software for only a fixed term, in most cases between a one- and three -year Support revenue is derived from providing technical customer support services, unspecified software updates and upgrades to customers several times a year, on a when -and-if-available Professional services revenues primarily consist of training and other professional services. Each of these performance obligations provide benefit to the customer on a standalone basis and are distinct in the context of the contract. The transaction price is determined based on the consideration to which the Company expects to be entitled in exchange for transferring products or delivery of services to the customer. Payment terms generally are net 30 days. The Company applied the practical expedient in ASC 606 and did not evaluate payment terms of one year or less for the existence of a significant financing component. Revenue is recognized net of any taxes collected from customers which are subsequently remitted to governmental entities (e.g., sales tax and other indirect taxes). The Company does not offer right of return to its contracts. If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. For contracts that contain multiple performance obligations, the Company allocates the transaction price to each performance obligation based on the relative standalone selling price (“SSP”) for each performance obligation. The Company uses judgment in determining the SSP for its products and services. The Company typically assesses the SSP for its products and services on a periodic basis or when facts and circumstances change. To determine SSP, the Company maximizes the use of observable standalone sales and observable data, where available. In instances where performance obligations do not have observable standalone sales, the Company utilizes available information that may include the entity specific factors such as assessment of historical data of bundled sales of software licenses with other promised goods and services, and pricing strategies to estimate the price the Company would charge if the products and services were sold separately. The Company satisfies performance obligations either over time or at a point in time depending on the nature of the underlying promise. Revenue is recognized at the time the related performance obligation is satisfied by transferring a promised good or service to a customer. Revenues related to the license for proprietary software are recognized when the control over the license is provided to the customer and the license term begins. Revenue related to software update and upgrades are recognized ratably over the service period. Revenues related to other professional services are generally recognized over time and in certain cases at point in time upon satisfaction of the performance obligation. Service revenues are included in the Company’s consolidated statements of income as service revenues. Disaggregation of Revenues The following table provides information about disaggregated revenue by geographical areas Year Ended December 31, 2021 2020 2019 EMEA $ 88,441 $ 65,807 $ 55,911 America 126,929 100,835 89,514 APAC 30,876 28,271 26,429 Total $ 246,246 $ 194,913 $ 171,854 Contract Balances The following table provides information about accounts receivable, contract assets, and contract liabilities from contracts with customers: December 31, 2021 December 31, 2020 Contract assets $ 8,567 $ 3,967 Contract liabilities, current 122,983 105,543 Contract liabilities, non-current $ 36,426 $ 33,439 Contract assets consist of unbilled accounts receivable, which occur when a right to consideration for the Company’s performance under the customer contract occurs before invoicing to the customer. The increase in contract balances is consistent with the increase in the overall operation of the Company. Contract liabilities consist of deferred revenue. Revenue is deferred when the Company invoices in advance of performance under a contract. The current portion of the deferred revenue balance is recognized as revenue during the 12 -month -month Remaining Performance Obligations The Company’s remaining performance obligations are comprised of product and services revenue not yet delivered. As of December 31, 2021 and December 31, 2020, the aggregate amount of the transaction price allocated to remaining performance obligations was $231,666 and $172,885 respectively, which consists of both billed consideration in the amount of $159,409 and $138,982 respectively, and unbilled consideration in the amount of $72,257 and $33,903 respectively, that the Company expects to recognize as revenue. As of December 31, 2021, the Company expects to recognize 61% of its remaining performance obligations as revenue in the year ended December 31, 2022 and the remainder thereafter. Contract acquisition costs The Company capitalizes sales commissions and associated payroll taxes paid to sales personnel that are incremental to obtaining customer contracts. These costs are recorded as deferred contract acquisition costs on the consolidated balance sheets. The Company determines whether costs should be deferred based on its sales compensation plans and if the commissions are incremental and would not have occurred absent the customer contract. Sales commissions for the renewal of a contract are considered commensurate with the sales commissions paid for the acquisition of the initial contract given no substantive difference in commission rates in proportion to their respective contract values. Sales commissions paid upon the initial acquisition and for the renewal of a contract are amortized over the contractual term of the initial contract or the renewal. Amortization of sales commissions are consistent with the pattern of revenue recognition of each performance obligation and are included in sales and marketing expense in the consolidated statements of operations. The Company periodically reviews these deferred contract acquisition costs to determine whether events or changes in circumstances have occurred that could impact the period of benefit. No impairment losses of capitalizes sales commissions were recorded during the periods presented. Commission expenses for the year ended December 31, 2021, 2020 and 2019 were $10,700, $8,400 and $6,800 respectively. K. Research and development costs Research and development costs are expensed as incurred. As defined by ASC Subtopic 985 -20 “Accounting for the Cost of Computer Software to be Sold, Leased or Otherwise Marketed” L. Product warranties The Company provides a one -year M. Advertising expenses Advertising expenses are charged to expense as incurred. Advertising expenses for the years 2021, 2020 and 2019 were $5,274, $4,098 and $5,315 respectively. N. Income taxes The Company accounts for income taxes in accordance with ASC 740, “Income Taxes” -term The Company implements a two -step O. Stock -Based Compensation The Company accounts for stock -based . -based The fair value of the shares of ordinary shares underlying the stock options has historically been determined by the Company’s board of directors as there was no public market for the underlying ordinary shares. The Company’s board of directors determines the fair value of the Company’s ordinary shares by considering a number of objective and subjective factors including: contemporaneous third -party -length For all share options granted, the Company calculated the expected term using the simplified method for “plain vanilla” stock option awards. The risk -free -coupon -based -Scholes -pricing -5 Stock based compensation costs have been included in income from operations. P. Fair value measurements The Company accounts for fair value in accordance with ASC 820, “Fair Value Measurements and Disclosures” -tier • • • The first two levels in the hierarchy are considered observable inputs and the last is considered unobservable. The carrying value of accounts receivable and payables and the Company’s cash and cash equivalents, restricted cash and short -term Derivative warrant liabilities Upon the closing of the transaction, 20,000,000 public warrants and 9,666,667 private warrants, that were both issued by TWC prior to the transaction, were outstanding to purchase the Company’s ordinary shares. Each warrant entitles the holder to purchase one Company Ordinary Share at a price of $11.50 per share, subject to adjustments. The warrants are exercisable at any time commencing 30 days after the completion of the transaction and expire five years after the Closing Date or earlier upon redemption or liquidation. The Company may redeem the outstanding public warrants in whole and not in part at a price of $0.01 per warrant at any time after they become exercisable, provided that the last sale price of the Company ordinary shares equals or exceeds $18 per share, subject to adjustments, for any 20 -trading -trading -40 The Public Warrants may be exercised with a different mechanism, depends on whether the Company maintain an effective registration statement or not. Since, among other things, the fact whether the Company maintains an effective registration statement effect the settlement provision of the Public Warrants (i.e., the cap is applicable depends on whether the registration statement is effective or not), is not an input into the pricing of fixed for fixed option model on equity shares, the Public Warrants are precluded from being indexed to the Company’s own stock and should be classified as a liability. Therefore, the public and private warrants were classified as a liability measured at fair value pursuant to ASC 480 “Distinguishing Liabilities from Equity” and ASC 815 “Derivatives and Hedging”. Public Private Total Warrant liability assumed from the Business Combination $ 34,400 $ 34,045 $ 68,445 Change in fair value of warrant liability 800 (12,767 ) (11,967 ) Balance, December 31, 2021 $ 35,200 $ 21,278 $ 56,478 The estimated fair value of the private placement warrant derivative liabilities is determined using Level 3 inputs. Inherent in a Black -Scholes -price -free -free -coupon the grant date for a maturity similar to the expiration of the warrants. The dividend yield is based on the historical rate, which the Company anticipates will remain at 0 -5 As of Number of private placement warrants 9,666,667 Exercise price $ Share price $ Expiration term (in years) 4.66 Volatility 44.8 Risk-free Rate 1.22 Dividend yield 0 Restricted sponsor shares liability and Price adjustment shares 7,500,000 Ordinary Shares issued to the Sponsor, out of a total of 13,500,000 -Closing Holders of the Company’s Ordinary Shares and vested Restricted Share Units, in each case as of immediately prior to the effective time, are eligible to receive up to 15,000,000 Ordinary Shares that will vest in 3 tranches of 5,000,000 upon achievement of the of the triggering events (if at any time during the Price Adjustment Period the price of Cellebrite Ordinary Shares will be greater than or equal to $12.50, $15.00 and $30.00, respectively, over any twenty trading days within any thirty trading day period.) or upon a Change of Control (as defined in business combination agreement) before the five (5) year anniversary of the Closing Date; The probability of such event was considered by the Company. Following the Merger, the Company issued equity and debt instrument. Transaction expenses were allocated on a relative fair value basis. Restricted Price Total Earn out shares assumed from the Business Combination $ 62,347 $ 117,675 $ 180,022 Change in fair value of warrant liability (17,635 ) (38,271 ) (55,906 ) Balance, December 31, 2021 $ 44,712 $ 79,404 $ 124,116 Q. Derivative instruments The Company has instituted a foreign currency cash flow hedging program using foreign currency forward contracts (“derivative instruments”) in order to hedge the exposure to variability in expected future cash flows resulting from changes in related foreign currency exchange rates. The Company hedges portions of its forecasted expenses denominated in NIS. These transactions are designated as cash flow hedges, as defined under ASC 815, “Derivatives and Hedging” As of December 31, 2021 and 2020, the amount recorded in accumulated other comprehensive income from the Company’s currency forward, net of tax, was $577 and $1,521, respectively. As of December 31, 2021, the notional amounts of foreign exchange forward contracts into which the Company entered were $15,623. The foreign exchange forward contracts will expire by May 13, 2022. The fair value of derivative instruments assets balances as of December 31, 2021 and 2020, totaled $964 and $2,016, respectively. R. Goodwill Goodwill represents the excess of the purchase price in a business combination over the fair value of the net tangible and intangible assets acquired. Under ASC 350, “Intangible — Goodwill and Other” ASC 350 requires goodwill to be tested for impairment at the reporting unit level at least annually, the fourth quarter, or between annual tests in certain circumstances, and written down when impaired. Goodwill is tested for impairment by comparing the fair value of the reporting unit with its carrying value. The Company has determined that it has one operating segment and one reporting unit. ASC 350 allows an entity to first assess qualitative factors to determine whether it is necessary to perform the two -step -step Alternatively, ASC 350 permits an entity to bypass the qualitative assessment for any reporting unit and proceed directly to performing the first step of the goodwill impairment test. There were no impairment charges to goodwill during the period presented. S. Intangible assets Intangible assets are amortized over their estimated useful lives using the straight -line Years Core technology 5 – 7 Trade name 4 Customer relationship 10 Each period the Company evaluates the estimated remaining useful lives of its intangible assets and whether events or changes in circumstances warrant a revision to the remaining period of amortization. T. Business combination The Company applies the provisions of ASC 805, “Business Combination” and allocates the fair value of purchase consideration to the tangible assets acquired, liabilities assumed, and intangible assets acquired based on their estimated fair values. The excess of the fair value of purchase consideration over the fair values of these identifiable assets and liabilities is recorded as goodwill. When determining the fair values of assets acquired and liabilities assumed, the Company estimated the future expected cash flows from acquired core technology and acquired trade name from a market participant perspective, useful lives and discount rates. In addition, management makes significant estimates and assumptions, which are uncertain, but believed to be reasonable. Significant estimates in valuing certain intangible assets include, but are not limited to future expected cash flows from acquired technology and acquired trademarks from a market participant perspective, useful lives and discount rates. Management’s estimates of fair value are based upon assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ from estimates. Acquisition -related U. Concentrations of credit risk Financial instruments that potentially expose the Company and its subsidiaries to concentrations of credit risk consist principally of cash and cash equivalents, short -term V. Segment reporting The Company identifies operating segments in accordance with ASC Topic 280, “Segment Reporting” as components of an entity for which discrete financial information is available and is regularly reviewed by the chief operating decision maker, or decision -making W. Basic and diluted net income (loss) per share The Company computes basic income (loss) per share in accordance with ASC Topic 260, “Earnings per Share” by dividing the income (loss) attributable to ordinary shareholders by the weighted average number of ordinary shares outstanding during the year. Diluted income (loss) per share is computed by taking into account the potential dilution that could occur upon the exercise of share options and vesting of RSUs granted under share based compensation plans using the treasury stock method. Basic and diluted income (loss) per share was presented in conformity with the two class method for participating securities for the year ended December 31, 2021, 2020 and 2019, as a result of a dividend distribution. The potentially dilutive share options to purchase ordinary shares that were excluded from the computation amounted to 9,995,236, 31,728,133 and 29,276,607 for the years ended December 31, 2021, 2020 and 2019, respectively, because including them would have been anti dilutive. The Earn -Out -Out Public warrants and Private warrants, were excluded from the diluted income per share for the year ended December 31, 2021, as the inclusion would have been anti dilutive. X. Recently issued accounting pronouncements As an “Emerging growth company,” the Jumpstart Our Business Startups Act (“JOBS Act”) allows the Company to delay adoption of new or revised accounting pronouncements applicable to public companies until such pronouncements are made applicable to private companies. The Company has elected to use this extended transition period under the JOBS Act. The adoption dates discussed below reflect this election. Recently adopted accounting pronouncements: • -08 ASU 2021 -08 The Company allocated the transaction price to each performance obligation based on the standalone selling price at the acquisition date. As a result of the amendments, it is expected that an acquirer will generally recognize and measure acquired contract assets and contract liabilities (deferred revenue) in a manner consistent with how the acquiree recognized and measured them in its preacquisition financial statements. In addition, as a result of the amendment, acquirer likely would subsequently recognize the same amount of revenue that the acquiree would have recognized if no business combination took place. The ASU will be effective for fiscal years beginning after December 15, 2022 and interim periods therein for public business entities. The Company early adopted the standard in 2021. Acquisitions of businesses assumed during the year ended December 31, 2021 were presented in conformity with the provisions of the standard. Recently issued accounting pronouncements not yet adopted: • -02 -of-use -type standard is effective for the annual periods beginning on or after January -USD • -13 ASU 2016 -13 • -12 -up Y. Certain comparative figures have been reclassified to conform to the current year presentation.

Business combination

Business combination	12 Months Ended
	Dec. 31, 2021
Business Combinations [Abstract]
Business combination	Note 3. Business combination a. Acquisition of BlackBag Technologies Inc.: On February 27, 2020, the Company completed the acquisition of 100% of the shares of BlackBag Technologies Inc. (“BlackBag”), a US computer collection and review solutions company, for a total consideration of $33,362. Out of the total consideration, $15,362 was paid in cash at the closing and additional $18,000 will be paid in three installments, $6,000 each year in the first, second and third anniversary of the closing. $13,000 out of the $18,000 are subject to the attainment of certain employee retention and are recognized over two years as payroll expenses and are not included within the total purchase price. Acquisition expenses were $1,848 during 2020 and consist of costs incurred to complete the acquisition and related integration charges. These charges were recorded in general and administrative expenses. Upon acquisition, BlackBag became a wholly owned subsidiary of the Company. The acquisition was accounted for as a business combination. The Company recorded trade name, core technology and goodwill in the amounts of $4,000, $3,900 and $9,463, respectively. The estimated useful life of the trade name and core technology are 4 years and 7 years, respectively. The Company recognized $1,289 and $1,546 amortization costs related to these intangible assets for the year ended December 31, 2021 and December 31, 2020, respectively. b. On April 8, 2021, the Company entered into a Business Combination Agreement and Plan of Merger (the “Merger Agreement”) with TWC Tech Holdings II Corp. (“TWC”), a public listed company in Nasdaq and Cupcake Merger Sub, Inc., a new wholly -owned consummated. Upon the terms and subject to the conditions of the Merger Agreement, at the Effective Time, Merger Sub merged with and into TWC, the separate corporate existence of Merger Sub ceased and TWC became the surviving corporation and a wholly -owned -owned On the date of Closing of the Merger (the “Closing”) and prior to the Merger becoming effective by acceptance of the Merger Certificate for filing by the Secretary of State of the State of Delaware, and prior to the Company’s Preferred Share conversion into Ordinary Shares as described below, an initial dividend of $21,300 (“Initial Dividend”) and an additional dividend of $78,700 (“Additional Dividend”) were paid to the holders of Company’s Ordinary Shares, Preferred Shares and vested restricted stock units (“RSU”) (all the “Company Shareholders”). Immediately after the payment of the Initial Dividend and the Additional Dividend and prior to the Effective Time each Company Preferred Share was automatically converted into Ordinary Share in accordance with the terms in Cellebrite’s Article of Association. Immediately following such conversion but prior to the Effective Time, the Company effected a reverse stock split of each Company Ordinary Share into such number of Company Ordinary Shares, which set the Ordinary Share value at $10 ( See also Note 12). Furthermore, Cellebrite issued TWC security holders the following securities at the Effective Time: each Public Share was converted into the right to receive one (1) Ordinary Share (the “Per Share Merger Consideration”). At the Effective Time each private warrant of TWC and each Public Warrant was converted into a warrant of Cellebrite, exercisable for the amount of Per Share Merger Consideration that the holder thereof would have received if such warrant had been exercisable and exercised immediately prior to the Business Combination. Additionally, each option and restricted stock unit of Cellebrite remain outstanding, subject to adjusted terms to reflect the effect of the Stock Split on Ordinary Shares. Concurrently with the execution of the Merger Agreement, certain accredited investors (the “PIPE Investors” and each, a “PIPE Investor”) entered into share purchase agreements (the “Share Purchase Agreements” and each, a “Share Purchase Agreement”) pursuant to which the PIPE Investors committed to purchase Ordinary Shares from certain Cellebrite shareholders at a purchase price of $10.00 per share in an aggregate number equal to 30,000,000 and an aggregate purchase price of $300,000 (the “PIPE Investments” and each, a “PIPE Investment”) on the closing date of August 30, 2021 (the “Closing Date”), which were converted into 30,000,000 Ordinary Shares upon the consummation of the Merger (the “PIPE Shares”). The PIPE Investment closed immediately prior to the Merger. c. Acquisition of Digital Clues carved Out Assets: On November 11, 2021, the Company completed the acquisition of Digital Clues LTD. (“DC”) carved out assets, for a total consideration of $20,000 . DC is an open -source The purchase price allocation for the acquisition has been determined as follows: Amount Net assets $ (890 ) Technology 3,347 Customer relationship 177 Goodwill 17,366 Total $ 20,000 Goodwill is primarily attributable to expected synergies arising from technology integration and expanded product availability to the Company’s existing and new customers. Goodwill is deductible for income tax purpose. The following table sets forth the components of identifiable intangible assets acquired and their estimated useful lives as of the date of acquisition: Fair Value Useful Life US$ thousands In years Core technology 3,347 7 Customer relationship 177 10 Total identifiable intangible assets $ 3,524 The Company recorded amortization expenses of $67 for the year ended December 31, 2021. Additionally, the Company incurred transaction costs $267 during the year ended December 31, 2021, which were included in general and administrative expenses in the Consolidated Statements of Operations.

Intangible assets, net

Intangible assets, net	12 Months Ended
	Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible assets, net	Note 4. Intangible assets, net a. Definite -lived intangible assets: December 31, 2021 December 31, 2020 Original amounts: Core technology $ 10,411 $ 4,000 Trade name 3,900 3,900 Customer relationship 177 — 14,488 7,900 Accumulated amortization: Core technology 1,470 476 Trade name 1,788 813 Customer relationship 2 — Intangible assets, net 3,260 1,289 $ 11,228 $ 6,611 b. Amortization expense amounted to $1,971, $1,289 and $0 for the years ended December 31, 2021, 2020 and 2019, respectively. c. The expected future amortization expenses by year related to the intangible assets as of December 31, 2021 are as follows: 2022 $ 2,655 2023 2,655 2024 1,843 2025 1,680 2026 and thereafter 2,395 $ 11,228

Short-Term Deposits

Short-Term Deposits	12 Months Ended
	Dec. 31, 2021
Debt Disclosure [Abstract]
Short-term deposits	Note 5. Short-term deposits Short -term -term -term

Prepaid Expenses and Other Curr

Prepaid Expenses and Other Current Assets	12 Months Ended
	Dec. 31, 2021
Prepaid expenses and other current assets [Abstract]
Prepaid expenses and other current assets	Note 6. Prepaid expenses and other current assets December 31, 2021 December 31, 2020 Advances to suppliers $ 827 $ 163 Prepaid expenses 8,927 4,319 Government institutions 1,662 811 Other 1,402 2,146 $ 12,818 $ 7,439

Inventories

Inventories	12 Months Ended
	Dec. 31, 2021
Inventory Disclosure [Abstract]
Inventories	Note 7. Inventories December 31, 2021 December 31, 2020 Raw materials $ 4,742 $ 3,279 Finished goods 1,769 1,475 $ 6,511 $ 4,754

Property and Equipment, Net

Property and Equipment, Net	12 Months Ended
	Dec. 31, 2021
Property, Plant and Equipment [Abstract]
Property and equipment, net	Note 8. Property and equipment, net December 31, 2021 December 31, 2020 Manufacturing equipment $ 526 $ 509 Furniture and equipment 8,294 6,898 Leasehold improvements 6,637 6,430 Computers and software 22,735 18,931 38,192 32,768 Less – accumulated depreciation (21,436 ) (16,662 ) $ 16,756 $ 16,106 Depreciation expenses were $5,036, $4,464 and $3,587 in the year ended December 31, 2021, 2020 and 2019, respectively.

Other Accounts Payable and Accr

Other Accounts Payable and Accrued Expenses	12 Months Ended
	Dec. 31, 2021
Payables and Accruals [Abstract]
Other accounts payable and accrued expenses	Note 9. Other accounts payable and accrued expenses December 31, 2021 December 31, 2020 Governmental institution $ 2,372 $ 2,192 Employees and related expenses 29,725 28,098 Income tax payable 8,235 6,610 Accrued expenses 12,800 11,037 Phantom option units liability — 538 Advances from customers 695 559 Other 217 78 $ 54,044 $ 49,112

Liability for Employees Severan

Liability for Employees Severance Benefits	12 Months Ended
	Dec. 31, 2021
Retirement Benefits [Abstract]
Liability for employees severance benefits	Note 10. Liability for employees severance benefits a. Under Israeli law and labor agreements, the Company is required to make severance payments to retired or terminated employees and to employees leaving employment in certain other circumstances. The liability of the Company to pay severance pay to its employees is covered by the provision and by the payment of premiums for insurance policies. The Company makes payments into a general provident fund. The amounts deposited in the provident fund and the amounts paid for insurance policies in the names of the companies include accrued profits and may be withdrawn subject to restrictions determined by law. b. According to Section 14 to the Severance Pay Law (“Section 14”) in Israel the payment of monthly deposits by a company into recognized severance and pension funds or insurance policies releases it from any additional severance obligation to the employees that have entered into agreements with the company pursuant to such Section 14. Commencing from 2007, the Company has entered into agreements with a majority of its employees in order to implement Section 14. Therefore, beginning that date, the payment of monthly deposits by the Company into recognized severance and pension funds or insurance policies releases it from any additional severance obligation to those employees that have entered into such agreements and therefore the Company incurs no additional liability since that date with respect to such employees. Amounts accumulated in the pension funds or insurance policies pursuant to Section 14 are not supervised or administrated by the Company and therefore neither such amounts nor the corresponding accrual are reflected in the Company’s Consolidated Financial Statements. In addition, we pay severance benefits to our employees located elsewhere in accordance with local laws and practices of the countries in which they are employed and as a result have no accumulated liability. For the year ended December 31, 2021, 2020 and 2019 severance pay expenses amounted to $4,067, $3,340 and $3,476 respectively. c. The US Subsidiary has a defined contribution plan (the “Contribution Plan”) under the provisions of Section 401(k) of the Internal Revenue Code (the “Code”) which covers eligible U.S. employees as they are defined in the Contribution Plan. Participants may elect to contribute up to a maximum amount prescribed by the Code. The Company, at its discretion, makes matching contributions equal to the greater of 6% of the participant’s compensation. For the year ended December 31, 2021 and 2020, the Company made 401(k) plan contributions of approximately $1,455, $877 and $774 , respectively.

Commitments

Commitments	12 Months Ended
	Dec. 31, 2021
Commitments [Abstract]
Commitments	Note 11. Commitments The Company has rent agreements for its offices and plants, that are accounted for as operating leases. The latest period included in the agreements will end by February 28, 2031. Certain agreements have extension options. Future minimum lease commitments under non -cancellable US$ 2022 $ 4,890 2023 4,251 2024 5,417 2025 2,221 2026 and thereafter 1,722 $ 18,501

Shareholders' Equity (Deficienc

Shareholders' Equity (Deficiency) and Redeemable Convertible Preferred Shares	12 Months Ended
	Dec. 31, 2021
Stockholders' Equity Note [Abstract]
Shareholders' equity (deficiency) and redeemable convertible preferred shares	Note 12. Shareholders’ equity (deficiency) and redeemable convertible preferred shares a. Stock Split On August 30, 2021, the Company’s board of directors approved a 1:1.0422 reverse stock split. As a result, all ordinary shares, Preferred Shares, options for ordinary shares, restricted share unites,exercise price and net income (loss) per share amounts were adjusted retroactively for all periods presented in these condensed consolidated financial statements as if the stock split and change in par value had been in effect as of the date of these condensed consolidated interim financial statements. b. Ordinary Shares As of December 31, 2021 and 2020, the Company was authorized to issue 3,454,112,863 Common stock confers upon its holders the following rights: (i.) The right to participate and vote in the Company’s general meetings. Each share will entitle its holder, when attending and participating in the voting to one vote; (ii.) Dividends or Distribution shall be paid or be made to the holders of Ordinary Shares, shall be in an amount equal the product of the dividend or distribution payable or made on each ordinary share determined as if all preferred shares had been converted into ordinary shares and the number of ordinary shares issuable upon conversion of such preferred share, in each case calculated on the record date for determination of holders entitled to receive such dividend or distribution; and (iii.) The right to a share in the distribution of the Company’s excess assets upon liquidation pro rata to the par value of the stock held by them. c. Redeemable Convertible Preferred shares rights On June 17, 2019, the Company issued 39,779,261 Convertible Preferred shares for $2.765 per share (the “Original Issue Price”) for the total consideration of $101,205 (net of issuance costs). On June 17, 2019, IGP Saferworld Limited Partnership (hereinafter: “IGP”), an investment vehicle of IGP Capital, a venture capital firm based in Israel, invested $110 million in the Company, in exchange for the Company’s redeemable convertible preferred shares, representing 24.4% of the Company’s outstanding ordinary and preferred shares (see also Note 3b and Note 12b). Following the IGP investment, the Company paid to its employees compensation in the amount of $4,034 includes in other expenses in the consolidated statements of operations and comprehensive income (loss). On August 30, 2021, immediately before the consummation of the Merger with TWC, the Company’s Preferred Shares were converted into Ordinary Shares. d. Acquisition of shares by the Company: During 2019, the Company acquired 295,000 e. Option Plan and RSU’s: On June 17, 2019, the Company adopted a restricted share and restricted share units (“RSU”) Plan and a Share Option Plan. Under the RSU Plan, the maximum aggregate number of Shares that may be issued pursuant to awards under this plan shall initially be 5,756,855 authorized but unissued shares, or such other number as the Board may determine from time to time. As for the Share Option Plan, the Company has reserved a total of 20,761,094 Shares for the purposes of the Plan and for the purposes of any other equity incentive plans which may in the future be adopted by the Company. On August 1, 2021, The Company adopted the 2021 (the “2021 Plan). The 2021 plan provides for the grant of share options (including incentive share options and non -qualified -based The maximum aggregate number of shares that may be issued pursuant to awards under this 2021 Plan is 28,075,309. Employee Share Purchase Plan: In August 2021, the Company adopted the 2021 Employee Share Purchase Plan (“ESPP”). The aggregate number of Shares that may be issued pursuant to rights granted under the Plan shall be 1,871,687 Shares. In addition, on the first day of each calendar year beginning on January 1, 2023 and ending on and including January 1, 2033, the number of Shares available for issuance under the Plan shall be increased by that number of Shares equal to the lesser of (a) 1.0% of the Shares outstanding on the last day of the immediately preceding calendar year, as determined on a fully diluted basis, and (b) such smaller number of Shares as may be determined by the Board. If any right granted under the Plan shall for any reason terminate without having been exercised, the Shares not purchased under such right shall again become available for issuance under the Plan. The weighted -average -based The fair value of options granted during the year ended December 31, 2021, December 31, 2020 and December 31, 2019 were calculated based on the following average assumptions: Year ended December 31, 2021 2020 2019 Contractual period in years 10 10 10 Volatility 35.9% – 52.7% 45.1% – 50.2% 43.1% – 45.2% Risk free interest rate 1.3% – 1.4% 0.1% – 1.0% 2.2% – 2.8% Dividend yield —% – 5% 0% – 5% 0% – 5% Exercise price $ $2.385 – $5.190 $2.485 – $3.533 Fair value of Ordinary Share 5.41 – $8.270 $1.950 – $5.190 $2.032 – $3.533 Due to the dividend distribution adjustment mechanism, the exercise price is reduced according to the specific option agreement with each employee. The Company used estimated volatility of comparable public companies to estimate the expected volatility used for the lattice model. The risk -free As of December 31, 2021 the aggregate amount of options and RSU outstanding is 27,276,343. A summary of the Company’s option activity and related information is as follows: Number of Weighted- Weighted- Outstanding at December 31, 2020 30,834,504 $ 2.724 8.14 Granted 70,678 5.036 Exercised 2,626,573 2.661 Forfeited 2,790,712 2.874 Outstanding at December 31, 2021 25,487,897 $ 2.837 7.03 Exercisable at December 31, 2021 16,158,817 $ 2.643 6.45 Number of Weighted- average Weighted- Outstanding at December 31, 2019 27,377,797 $ 3.033 8.59 Granted 9,909,539 2.215 Exercised 693,101 2.238 Forfeited 5,759,731 3.485 Outstanding at December 31, 2020 30,834,504 2.724 8.14 Exercisable at December 31, 2020 13,828,828 2.618 5.70 The weighted average fair values at grant date of options granted for the year ended December 31, 2021 and 2020; with an exercise price equal to the value at the date of grant were $5.04 and $0.74 per share, respectively. The total intrinsic value of options exercised during the years 2021 and 2020 was $8,547 and $2,171 respectively. The aggregate intrinsic value of the outstanding options at December 31, 2021 and 2020, represents the intrinsic value of 25,440,041 and 29,414,990, respectively, outstanding options that are in -the-money -of-the-money A summary of the Company’s RSUs activity is as follows: December 31, December 31, Unvested at beginning of year 893,629 1,898,810 Granted 1,393,208 257,638 Vested* 178,254 805,716 Forfeited 65,059 457,103 Unvested, at end of year 2,043,524 893,629 __________ * 229,156 RSUs subject to deferral arrangements (“DSUs”) under the 2019 Restricted Share and Restricted Share Units Plan, that were vested as of Dec -31 The weighted average fair value at grant date of RSUs granted for the year ended December 31, 2020 and 2021 was $1.95 and $8.27 respectively The total fair value of shares vested during the years 2021 and 2020 was $927 and $4,327, respectively. As of December 31, 2021, the Company had approximately $20,316 of unrecognized compensation expense related to non -vested -vested -based Subsequent to year end, during February, the Company’s board of directors approved additional grant 4,559,059 stock based compensation to its employees. f. Stock based compensation costs are recorded in the consolidated statements of operations were as follows: Year Ended December 31, 2021 2020 2019 Cost of revenues $ 290 $ 304 $ 190 Research and development 1,076 1,145 1,212 Sales and marketing 2,332 2,298 2,969 General and administrative 2,782 3,524 8,388 $ 6,480 $ 7,271 $ 12,759

Net Income (Loss) Per Share

Net Income (Loss) Per Share	12 Months Ended
	Dec. 31, 2021
Earnings Per Share [Abstract]
Net income (loss) per share	Note 13. Net income (loss) per share The following table sets forth the computation of basic losses per share: Year Ended December 31, 2021 2020 2019 Numerator: Net income (loss) $ 71,396 $ 5,781 $ (1,876 ) Basic net income attributable to Preferred shareholders — 15,125 8,163 Basic net income attributable to Restricted sponsor shares 963 — — Basic net income (loss) attributable to Ordinary shareholders 70,433 (9,344 ) (10,039 ) Denominator: Weighted average number of Ordinary shares used in computing basic net income (loss) per share 144,002,394 123,696,624 121,560,817 Basic net income (loss) per share of Ordinary shareholders $ 0.49 $ (0.08 ) $ (0.08 ) Weighted average number of Ordinary shares used in computing diluted net income (loss) per share 161,538,579 123,696,624 121,560,817 Diluted net income (loss) per share of Ordinary shareholders $ 0.44 $ (0.08 ) $ (0.08 )

Revenues

Revenues	12 Months Ended
	Dec. 31, 2021
Revenue from Contract with Customer [Abstract]
Revenues	Note 14. Revenues Year Ended December 31, 2021 2020 2019 Revenues from subscription services $ 120,889 $ 100,614 $ 81,505 Revenues from term-license 62,428 29,131 5,142 Total revenues from subscription 183,317 129,745 86,647 Revenues from perpetual license and other 34,169 42,136 59,175 Revenues from professional services 28,760 23,032 26,032 $ 246,246 $ 194,913 $ 171,854 Including related party revenues in the amount of $3,678, $1,865 and $3,662 in 2021, 2020 and 2019, respectively.

Cost of revenues

Cost of revenues	12 Months Ended
	Dec. 31, 2021
Cost of revenues [Abstract]
Cost of revenues	Note 15. Cost of revenues Year Ended December 31, 2021 2020 2019 Materials and changes in inventories $ 10,316 $ 10,532 $ 7,638 Payroll and related expenses 19,754 17,019 14,272 Training expenses 3,885 2,713 5,338 Shipping expenses 1,548 1,543 1,784 Depreciation and Amortization 1,080 1,327 1,501 Inventory write-off 230 150 262 Travel 1,410 866 1,561 Other 4,334 3,729 3,467 $ 42,557 $ 37,879 $ 35,823 Cost of revenues by revenue type Year Ended December 31, 2021 2020 2019 Cost of revenues from subscription services $ 9,369 $ 8,795 $ 6,585 Cost of term-license 2,299 1,709 189 Cost of revenues from perpetual license and 9,817 9,370 10,049 Cost of revenues from professional services 21,072 18,005 19,000 $ 42,557 $ 37,879 $ 35,823

Sales and marketing

Sales and marketing	12 Months Ended
	Dec. 31, 2021
Sales and marketing [Abstract]
Sales and marketing	Note 16. Sales and marketing Year Ended December 31, 2021 2020 2019 Payroll and related expenses $ 48,901 $ 39,991 $ 36,559 Sales commissions 10,312 8,246 6,624 Marketing and advertising 5,274 4,098 5,322 Travel and entertainment 2,279 1,276 4,939 Rent and maintenance 2,513 2,640 2,661 Depreciation and amortization 1,872 1,877 824 Vehicle costs 466 423 448 Professional consultants 1,349 808 1,889 Recruiting expenses 1,043 330 859 Other 2,380 1,616 1,485 $ 76,389 $ 61,305 $ 61,610

Research and development

Research and development	12 Months Ended
	Dec. 31, 2021
Research and development [Abstract]
Research and development	Note 17. Research and development Year Ended December 31, 2021 2020 2019 Payroll and related expenses $ 53,683 $ 45,716 39,142 Rent and maintenance 1,851 2,117 1,721 Subcontractors and projects 3,482 2,676 2,398 Travel and entertainment 185 20 314 Vehicle costs 232 270 355 Recruiting expenses 178 127 222 Depreciation and amortization 2,100 1,813 1,135 Other 3,830 1,638 1,286 $ 65,541 $ 54,377 $ 46,573

General and administrative

General and administrative	12 Months Ended
	Dec. 31, 2021
General and Administrative [Abstract]
General and administrative	Note 18. General and administrative Year Ended December 31, 2021 2020 2019 Payroll and related expenses $ 19,366 $ 18,460 16,386 Professional fees 4,307 4,274 2,040 Vehicle costs 469 328 263 Rent and maintenance 1,559 2,147 2,071 Travel and entertainment 249 262 425 Refreshments, gifts and donations 525 778 645 Doubtful accounts and bad debts 676 606 266 Recruiting expenses 727 330 386 Depreciation 1,955 978 484 Issuance costs 11,835 — — Other 6,269 3,971 6,402 $ 47,937 $ 32,134 $ 29,368

Taxes on income

Taxes on income	12 Months Ended
	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Taxes on income	Note 19. Taxes on income A. Israeli taxation 1. Corporate tax rates in Israel: The tax rates relevant to corporations in Israel in the years 2021, 2020 and 2019 is 23%. However, the effective tax rate reported by a company that derives income from a Preferred Enterprise or Preferred Technological Enterprise (as discussed below) is lower. 2. Tax benefits under the Law for Encouragement of Capital Investments, 1959 (“the Investment Law”) Approved/Beneficiary Enterprise Pursuant to the Investment Law, the Company was awarded “Approved Enterprise” and “Beneficiary Enterprise” status under the government alternative benefits path beginning in 2003 until 2018 (included). During this period the Company was entitled to beneficial tax rates of 0% – 10%. The Company decided to terminate its “Approved” and ”Beneficiary Enterprise” status early and enjoy beneficial tax rates under the “preferred technological enterprise” status effective beginning 2019. In the event of distribution of dividends from income taxable at 0% tax rate as part of the Approved Enterprise or Beneficiary Enterprise statuses, the amount distributed will be subject to corporate tax at the rate ordinarily applicable to the Approved or Beneficiary Enterprise’s. During the year ended December 31, 2021, the Company distributed approximately $71,000 attributable to these “trapped earnings” and recorded a related income tax expense of approximately $7,000. As of December 31, 2021, the Company has no remaining trapped earnings that would generate a tax liability, if distributed. On November 15, 2021, the Israeli Economic Efficiency Law for the years 2021 and 2022 was enacted, which consists of numerous legislative amendments and arrangements, including an amendment to Section 74 of the Encouragement Law, which deals with the identification of sources of dividend distributions as of August 15, 2021 (hereinafter — the amendment). The amendment stipulates that in any dividend distribution from companies holding accumulated profits that were exempt from tax until their distribution as a dividend (“trapped earnings”), a certain part of the distribution will be considered a distribution of those trapped earnings, which will be fully taxed upon release. In addition, a temporary provision to the Encouragement Law was enacted, which offers a reduced tax payment arrangement to companies that have trapped earnings. The temporary provision, which is valid until November 14, 2022, stipulates that companies that have chosen to apply it, will be entitled to a tax rebate on corporate income tax, for the released trapped earnings. The release of trapped earnings allows their distribution at a beneficiary corporate tax rate according to the ratio of the distributed profits. The beneficiary corporate tax will be determined according to the ratio of the trapped earnings that the company seeks to release from all its trapped earnings. It will range between 40% to 70% of the corporate tax rate that would have applied to income in the year it was generated, but in any case, not less than 6%. Eligibility for the beneficiary corporate tax rate is conditional on a company’s decision to release part or all of its trapped earnings and the payment of the tax due until November 14, 2022, as well as on making investments in the companies’ industrial plants over five Preferred Enterprise and Preferred Technology Enterprise Preferred Enterprise and Preferred Technology Enterprise On May 16, 2017 the Knesset Finance Committee approved Encouragement of Capital Investment Regulations (Preferred Technological Income and Capital Gain of Technological Enterprise) — 2017 (hereinafter: “the Regulations”), which provides rules for applying the “Preferred Technological Enterprise” tax benefit track including the formula that provides the mechanism for allocating the technological income eligible for the benefits Commencing in 2019 the Company elected the Preferred Technology Enterprise status to apply under the Law for the Encouragement of Capital Investments (the “Investment Law”). The approval is currently in affect for the tax years 2019 to 2023. The Company expects to continue to meet the conditions to be entitled to the “Preferred Technological Enterprise” status beyond 2023. Income subject to the Preferred Technology Enterprise status is taxed at reduced tax rate of 12% and income from manufacturing activity in Area A is taxed at reduced tax rate of 7.5%. 3. Foreign Exchange Regulations: Under the Foreign Exchange Regulations, the Company calculates its Israeli tax liability in U.S. dollars according to certain orders. The tax liability, as calculated in U.S. dollars is translated into NIS according to the exchange rate as of December 31 of each year. B. Income taxes on non -Israeli subsidiaries: The Company’s subsidiaries incorporated in the US, Germany, Singapore, Australia, Brazil, UK, France, Canada, Japan and India are taxed according to tax laws in the countries of their residence. The Company’s effective tax rate depends on the geographical mix of where its profits are earned. In the year 2021, the Company’s U.S. subsidiary is subject to combined federal and state income taxes of 26% and the subsidiaries in Germany and Singapore are subject to corporation tax at a rate of approximately 33% and 17% respectively. As of December 31, 2021, the Company had approximately $25,768 undistributed earnings of its subsidiaries for which a deferred tax liability of approximately $4,125 was not recognized. These undistributed earnings were designated as indefinitely reinvested. In the event of a distribution of those earnings in the form of dividends, a sale of the subsidiaries, or certain other transactions, we may be liable for income taxes, subject to an adjustment, if any, for foreign tax credits and foreign withholding taxes payable to certain foreign tax authorities C. Deferred taxes Deferred taxes recognized for the tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and such amounts for income tax purposes. Significant components of the deferred tax liabilities and assets are as follows: December 31, 2021 December 31, 2020 Deferred tax assets: Deferred research and development cost $ 3,556 $ 4,970 Employee related liabilities 842 906 Intangible assets 1,125 1,304 Goodwill 2,773 1,354 Deferred revenues 1,765 1,164 Issuance costs 1,347 — Other 1,068 431 Total deferred tax assets 12,476 10,129 Deferred tax liabilities: Deferred costs 1,324 1,242 Intangible assets 545 771 Goodwill 180 68 Property and equipment 438 455 Derivative instruments 79 208 Other 110 13 Total deferred tax liabilities 2,676 2,757 Total deferred tax assets, net $ 9,800 $ 7,372 A reconciliation of the amount that would result from applying the Company’s e statutory tax rate in Israel to income before income tax expense to the reported amount of income tax expense allocated to continuing operations is as follows: Year Ended December 31, 2021 2020 2019 Income before income taxes expense, as reported in the consolidated statements of operations $ 82,305 $ 11,397 $ 1,415 Statutory tax rate in Israel 23 % 23 % 23 % Theoretical taxes on income 18,930 2,621 325 Foreign subsidiaries taxed at different tax rates 167 81 76 Preferred tax rates in Israel (7,598 ) (72 ) 937 Revaluation of liability instruments (8,145 ) — — Non-deductible expense 1,363 1,501 2,293 Taxes in respect of prior years (125 ) 78 (283 ) Intercompany transfer of intangible assets — 1,324 — Tax on dividend distributed from trapped earnings 7,068 — — Other (751 ) 83 (57 ) Actual income tax expense $ 10,909 $ 5,616 $ 3,291 Income before income tax expense is comprised as follows: Year Ended December 31, 2021 2020 2019 Domestic $ 71,434 $ 4,348 $ (3,920 ) Foreign 10,871 7,049 5,335 $ 82,305 $ 11,397 $ 1,415 Income tax expenses allocated to continuing operations is comprised as follows: Year Ended December 31, 2021 2020 2019 Current: Israel $ 9,665 $ 4,549 $ 3,950 Foreign 2,882 3,885 1,008 Total current tax expense: 12,547 8,434 4,958 Deferred: Israel (10 ) (3,729 ) (1,897 ) Foreign (1,628 ) 911 230 Total deferred tax benefit (1,638 ) (2,818 ) (1,667 ) Total income tax expense $ 10,909 $ 5,616 $ 3,291 A reconciliation of the beginning and ending balances of the total amounts of unrecognized tax benefits is as follows: December 31, 2021 December 31, 2020 Unrecognized tax benefits, beginning of year $ 2,007 $ 1,689 Decreases in tax positions for prior years — (388 ) Increases in tax positions for current year 1,231 706 Unrecognized tax benefits, end of year $ 3,238 $ 2,007 Interest expense recognized related to uncertain tax positions amounted to $92, $25 and $51 in 2021, 2020 and 2019, respectively. Total accrued interest as of December 31, 2021 and 2020 was $168 and $76, respectively, and were included in accrued expenses. The Company currently does not expect unrecognized tax benefits to change significantly over the next 12 months, except in the case of settlements with tax authorities, the likelihood and timing of which is difficult to estimate. The Company’s income tax assessments in Israel through the year 2016 are considered final and the Company is currently under routine income tax audit for tax years 2017 -2018 The Company is subject to income tax in other jurisdictions outside of Israel, of which the major jurisdiction is the U.S. The Company’s operation in the US is subject to examination for tax years 2016 and afterwards. Timing of the resolution of audits is highly uncertain and therefore, as of December 31, 2021, the Company cannot estimate the change in unrecognized tax benefits resulting from these audits within the next 12 months.

Financial income, net

Financial income, net	12 Months Ended
	Dec. 31, 2021
Financial income, net [Abstract]
Financial income, net	Note 20. Financial income, net Year Ended December 31, 2021 2020 2019 Financial income: Interest on deposits $ 847 $ 2,710 $ 3,475 Foreign currency translation differences $ 51 780 380 Revaluation of liability instruments $ 67,873 — — Other $ 276 112 — Financial expenses: Bank charges $ (166 ) (197 ) (222 ) Changes in exchange rates $ (245 ) (1,226 ) (568 ) Other $ (153 ) — (130 ) $ 68,483 $ 2,179 $ 2,935

Dividend distribution

Dividend distribution	12 Months Ended
	Dec. 31, 2021
Dividend Distribution [Abstract]
Dividend distribution	Note 21. Dividend distribution In 2021 and 2020 the Board of Directors declared and distributed a dividend of $100,000 and $10,000, respectively, which were paid during the year. The dividend distributions were subject to a withholding tax at the shareholder’s level at the rate of 5% – 25%. See also note 3b.

Transactions and Balances With

Transactions and Balances With Related Parties	12 Months Ended
	Dec. 31, 2021
Related Party Transactions [Abstract]
Transactions and Balances with Related Parties	Note 22. Transactions and Balances with Related Parties A. Transactions with SUN Corporation Year Ended December 31, 2021 December 31, 2020 December 31, 2019 Revenues 3,678 1,865 3,662 B. Balances with SUN Corporation December 31, 2021 December 31, 2020 Trade receivables 214 — Trade payables — (154 )

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	12 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
Basis of presentation	A. Basis of presentation The consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (US GAAP). The significant accounting policies followed in the preparation of the financial statements, applied on a consistent basis for all years presented in these financial statements.
Functional Currency and Foreign Currency Translation	B. Functional Currency and Foreign Currency Translation A majority of the Company’s revenues are generated outside of Israel and are denominated in US dollars (“US$” or “dollars”). Substantial portion of materials and components cost, and marketing costs, are denominated in dollars or dollar -linked Transactions in foreign currency are translated into dollars in accordance with the principles set forth in ASC Subtopic 830 -20 Foreign Currency Transaction -monetary The effect of the translating into dollars has been included in the consolidated statements of shareholders’ equity and comprehensive income (loss) as a foreign currency translation adjustment. Gains and losses from remeasurement assets and liabilities denominated in currencies other than the respective functional currencies are included in the consolidated statements of operations.
Use of estimates	C. Use of estimates The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods and accompanying notes. Actual results could differ from those estimates. Significant items subject to such estimates and assumptions include, but are not limited to, the allocation of transaction price among various performance obligation, the fair value of acquired intangible assets and goodwill, share -based
Principles of consolidation	D. Principles of consolidation The accompanying consolidated financial statements include the accounts of the Company and its subsidiaries. All intercompany transactions and balances were eliminated in consolidation.
Cash and cash equivalents and restricted cash	E. Cash and cash equivalents and restricted cash The Company considers all highly liquid instruments with a maturity of three months or less at the date of purchase to be cash equivalents. Restricted cash consists of funds that are contractually restricted as to usage or withdrawal mainly due to a contractual agreement with an investor. The Company has presented restricted cash separately from cash and cash equivalents in the consolidated balance sheets.
Trade Receivable	F. Trade Receivable Trade receivables are recorded at the invoiced amount net of allowance for doubtful accounts. The allowance for doubtful accounts is based on the Company’s assessment of in the collectability of accounts. The Company regularly reviews the adequacy of the allowance for doubtful accounts based on combination of factors, including as assessment of the current customer’s aging report, the nature and size of the customer, the financial condition of the customer and the amount of any receivables in dispute. Trade receivables deemed uncollectible are charged off against the allowance for doubtful accounts after all means of collection have been exhausted and the potential for recovery is considered remote.
Inventories	G. Inventories Inventories are stated at the lower of cost or net realizable value. Cost is determined by the “weighted moving average” method. Inventory write -downs Inventory write -down -cost
Property and equipment	H. Property and equipment Property and equipment are stated at cost less accumulated depreciation. Depreciation is calculated by the straight -line % Computers and software 12.5 – 33 Manufacturing equipment 7 Office furniture and equipment 7 – 15 Leasehold improvements * ___________ * Over the shorter of the expected lease term or estimated useful lives.
Impairment of long-lived assets	I. Impairment of long -lived assets Long -lived Accounting for the impairment of Long -Lived Assets -lived -party -lived During the year ended December 31, 2021, 2020 and 2019, no impairment losses have been identified.
Revenue recognition	J. Revenue recognition The Company’s revenues are comprised of four main categories: (a) subscription revenues, including support services (updates, upgrades and technical support) on term -based -based The Company recognizes revenue pursuant to the five -step The Company sells its products to its customers either directly or indirectly through distribution channels all of whom are considered end users. In accordance with ASC 606, revenue is recognized when a customer obtains control of promised goods or services are delivered. The amount of revenue recognized reflects the consideration that the Company expects to receive in exchange for these goods or services. The Company determines that it has a contract with a customer when each party’s rights regarding the products or services to be transferred can be identified, the payment terms for the services can be identified, the Company has determined the customer has the ability and intent to pay, and the contract has commercial substance. At contract inception, the Company evaluates whether two or more contracts should be combined and accounted for as a single contract and whether the combined or single contract includes more than one performance obligation. Performance obligations promised in a contract are identified based on the products and services that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the products or services either on their own or together with other resources that are readily available from third parties or from the Company, and are distinct in the context of the contract, whereby the transfer of the products and services is separately identifiable from other promises in the contract. The Company’s software licenses either provide its customers a perpetual right to use its software or the right to use its software for only a fixed term, in most cases between a one- and three -year Support revenue is derived from providing technical customer support services, unspecified software updates and upgrades to customers several times a year, on a when -and-if-available Professional services revenues primarily consist of training and other professional services. Each of these performance obligations provide benefit to the customer on a standalone basis and are distinct in the context of the contract. The transaction price is determined based on the consideration to which the Company expects to be entitled in exchange for transferring products or delivery of services to the customer. Payment terms generally are net 30 days. The Company applied the practical expedient in ASC 606 and did not evaluate payment terms of one year or less for the existence of a significant financing component. Revenue is recognized net of any taxes collected from customers which are subsequently remitted to governmental entities (e.g., sales tax and other indirect taxes). The Company does not offer right of return to its contracts. If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. For contracts that contain multiple performance obligations, the Company allocates the transaction price to each performance obligation based on the relative standalone selling price (“SSP”) for each performance obligation. The Company uses judgment in determining the SSP for its products and services. The Company typically assesses the SSP for its products and services on a periodic basis or when facts and circumstances change. To determine SSP, the Company maximizes the use of observable standalone sales and observable data, where available. In instances where performance obligations do not have observable standalone sales, the Company utilizes available information that may include the entity specific factors such as assessment of historical data of bundled sales of software licenses with other promised goods and services, and pricing strategies to estimate the price the Company would charge if the products and services were sold separately. The Company satisfies performance obligations either over time or at a point in time depending on the nature of the underlying promise. Revenue is recognized at the time the related performance obligation is satisfied by transferring a promised good or service to a customer. Revenues related to the license for proprietary software are recognized when the control over the license is provided to the customer and the license term begins. Revenue related to software update and upgrades are recognized ratably over the service period. Revenues related to other professional services are generally recognized over time and in certain cases at point in time upon satisfaction of the performance obligation. Service revenues are included in the Company’s consolidated statements of income as service revenues. Disaggregation of Revenues The following table provides information about disaggregated revenue by geographical areas Year Ended December 31, 2021 2020 2019 EMEA $ 88,441 $ 65,807 $ 55,911 America 126,929 100,835 89,514 APAC 30,876 28,271 26,429 Total $ 246,246 $ 194,913 $ 171,854 Contract Balances The following table provides information about accounts receivable, contract assets, and contract liabilities from contracts with customers: December 31, 2021 December 31, 2020 Contract assets $ 8,567 $ 3,967 Contract liabilities, current 122,983 105,543 Contract liabilities, non-current $ 36,426 $ 33,439 Contract assets consist of unbilled accounts receivable, which occur when a right to consideration for the Company’s performance under the customer contract occurs before invoicing to the customer. The increase in contract balances is consistent with the increase in the overall operation of the Company. Contract liabilities consist of deferred revenue. Revenue is deferred when the Company invoices in advance of performance under a contract. The current portion of the deferred revenue balance is recognized as revenue during the 12 -month -month Remaining Performance Obligations The Company’s remaining performance obligations are comprised of product and services revenue not yet delivered. As of December 31, 2021 and December 31, 2020, the aggregate amount of the transaction price allocated to remaining performance obligations was $231,666 and $172,885 respectively, which consists of both billed consideration in the amount of $159,409 and $138,982 respectively, and unbilled consideration in the amount of $72,257 and $33,903 respectively, that the Company expects to recognize as revenue. As of December 31, 2021, the Company expects to recognize 61% of its remaining performance obligations as revenue in the year ended December 31, 2022 and the remainder thereafter. Contract acquisition costs The Company capitalizes sales commissions and associated payroll taxes paid to sales personnel that are incremental to obtaining customer contracts. These costs are recorded as deferred contract acquisition costs on the consolidated balance sheets. The Company determines whether costs should be deferred based on its sales compensation plans and if the commissions are incremental and would not have occurred absent the customer contract. Sales commissions for the renewal of a contract are considered commensurate with the sales commissions paid for the acquisition of the initial contract given no substantive difference in commission rates in proportion to their respective contract values. Sales commissions paid upon the initial acquisition and for the renewal of a contract are amortized over the contractual term of the initial contract or the renewal. Amortization of sales commissions are consistent with the pattern of revenue recognition of each performance obligation and are included in sales and marketing expense in the consolidated statements of operations. The Company periodically reviews these deferred contract acquisition costs to determine whether events or changes in circumstances have occurred that could impact the period of benefit. No impairment losses of capitalizes sales commissions were recorded during the periods presented. Commission expenses for the year ended December 31, 2021, 2020 and 2019 were $10,700, $8,400 and $6,800 respectively.
Research and development costs	K. Research and development costs Research and development costs are expensed as incurred. As defined by ASC Subtopic 985 -20 “Accounting for the Cost of Computer Software to be Sold, Leased or Otherwise Marketed”
Product warranties	L. Product warranties The Company provides a one -year
Advertising expenses	M. Advertising expenses Advertising expenses are charged to expense as incurred. Advertising expenses for the years 2021, 2020 and 2019 were $5,274, $4,098 and $5,315 respectively.
Income taxes	N. Income taxes The Company accounts for income taxes in accordance with ASC 740, “Income Taxes” -term The Company implements a two -step
Stock-Based Compensation	O. Stock -Based Compensation The Company accounts for stock -based . -based The fair value of the shares of ordinary shares underlying the stock options has historically been determined by the Company’s board of directors as there was no public market for the underlying ordinary shares. The Company’s board of directors determines the fair value of the Company’s ordinary shares by considering a number of objective and subjective factors including: contemporaneous third -party -length For all share options granted, the Company calculated the expected term using the simplified method for “plain vanilla” stock option awards. The risk -free -coupon -based -Scholes -pricing -5
Fair value measurements	P. Fair value measurements The Company accounts for fair value in accordance with ASC 820, “Fair Value Measurements and Disclosures” -tier • • • The first two levels in the hierarchy are considered observable inputs and the last is considered unobservable. The carrying value of accounts receivable and payables and the Company’s cash and cash equivalents, restricted cash and short -term Derivative warrant liabilities Upon the closing of the transaction, 20,000,000 public warrants and 9,666,667 private warrants, that were both issued by TWC prior to the transaction, were outstanding to purchase the Company’s ordinary shares. Each warrant entitles the holder to purchase one Company Ordinary Share at a price of $11.50 per share, subject to adjustments. The warrants are exercisable at any time commencing 30 days after the completion of the transaction and expire five years after the Closing Date or earlier upon redemption or liquidation. The Company may redeem the outstanding public warrants in whole and not in part at a price of $0.01 per warrant at any time after they become exercisable, provided that the last sale price of the Company ordinary shares equals or exceeds $18 per share, subject to adjustments, for any 20 -trading -trading -40 The Public Warrants may be exercised with a different mechanism, depends on whether the Company maintain an effective registration statement or not. Since, among other things, the fact whether the Company maintains an effective registration statement effect the settlement provision of the Public Warrants (i.e., the cap is applicable depends on whether the registration statement is effective or not), is not an input into the pricing of fixed for fixed option model on equity shares, the Public Warrants are precluded from being indexed to the Company’s own stock and should be classified as a liability. Therefore, the public and private warrants were classified as a liability measured at fair value pursuant to ASC 480 “Distinguishing Liabilities from Equity” and ASC 815 “Derivatives and Hedging”. Public Private Total Warrant liability assumed from the Business Combination $ 34,400 $ 34,045 $ 68,445 Change in fair value of warrant liability 800 (12,767 ) (11,967 ) Balance, December 31, 2021 $ 35,200 $ 21,278 $ 56,478 The estimated fair value of the private placement warrant derivative liabilities is determined using Level 3 inputs. Inherent in a Black -Scholes -price -free -free -coupon the grant date for a maturity similar to the expiration of the warrants. The dividend yield is based on the historical rate, which the Company anticipates will remain at 0 -5 As of Number of private placement warrants 9,666,667 Exercise price $ Share price $ Expiration term (in years) 4.66 Volatility 44.8 Risk-free Rate 1.22 Dividend yield 0 Restricted sponsor shares liability and Price adjustment shares 7,500,000 Ordinary Shares issued to the Sponsor, out of a total of 13,500,000 -Closing Holders of the Company’s Ordinary Shares and vested Restricted Share Units, in each case as of immediately prior to the effective time, are eligible to receive up to 15,000,000 Ordinary Shares that will vest in 3 tranches of 5,000,000 upon achievement of the of the triggering events (if at any time during the Price Adjustment Period the price of Cellebrite Ordinary Shares will be greater than or equal to $12.50, $15.00 and $30.00, respectively, over any twenty trading days within any thirty trading day period.) or upon a Change of Control (as defined in business combination agreement) before the five (5) year anniversary of the Closing Date; The probability of such event was considered by the Company. Following the Merger, the Company issued equity and debt instrument. Transaction expenses were allocated on a relative fair value basis. Restricted Price Total Earn out shares assumed from the Business Combination $ 62,347 $ 117,675 $ 180,022 Change in fair value of warrant liability (17,635 ) (38,271 ) (55,906 ) Balance, December 31, 2021 $ 44,712 $ 79,404 $ 124,116
Derivative instruments	Q. Derivative instruments The Company has instituted a foreign currency cash flow hedging program using foreign currency forward contracts (“derivative instruments”) in order to hedge the exposure to variability in expected future cash flows resulting from changes in related foreign currency exchange rates. The Company hedges portions of its forecasted expenses denominated in NIS. These transactions are designated as cash flow hedges, as defined under ASC 815, “Derivatives and Hedging” As of December 31, 2021 and 2020, the amount recorded in accumulated other comprehensive income from the Company’s currency forward, net of tax, was $577 and $1,521, respectively. As of December 31, 2021, the notional amounts of foreign exchange forward contracts into which the Company entered were $15,623. The foreign exchange forward contracts will expire by May 13, 2022. The fair value of derivative instruments assets balances as of December 31, 2021 and 2020, totaled $964 and $2,016, respectively.
Goodwill	R. Goodwill Goodwill represents the excess of the purchase price in a business combination over the fair value of the net tangible and intangible assets acquired. Under ASC 350, “Intangible — Goodwill and Other” ASC 350 requires goodwill to be tested for impairment at the reporting unit level at least annually, the fourth quarter, or between annual tests in certain circumstances, and written down when impaired. Goodwill is tested for impairment by comparing the fair value of the reporting unit with its carrying value. The Company has determined that it has one operating segment and one reporting unit. ASC 350 allows an entity to first assess qualitative factors to determine whether it is necessary to perform the two -step -step Alternatively, ASC 350 permits an entity to bypass the qualitative assessment for any reporting unit and proceed directly to performing the first step of the goodwill impairment test. There were no impairment charges to goodwill during the period presented.
Intangible assets	S. Intangible assets Intangible assets are amortized over their estimated useful lives using the straight -line Years Core technology 5 – 7 Trade name 4 Customer relationship 10 Each period the Company evaluates the estimated remaining useful lives of its intangible assets and whether events or changes in circumstances warrant a revision to the remaining period of amortization.
Business combination	T. Business combination The Company applies the provisions of ASC 805, “Business Combination” and allocates the fair value of purchase consideration to the tangible assets acquired, liabilities assumed, and intangible assets acquired based on their estimated fair values. The excess of the fair value of purchase consideration over the fair values of these identifiable assets and liabilities is recorded as goodwill. When determining the fair values of assets acquired and liabilities assumed, the Company estimated the future expected cash flows from acquired core technology and acquired trade name from a market participant perspective, useful lives and discount rates. In addition, management makes significant estimates and assumptions, which are uncertain, but believed to be reasonable. Significant estimates in valuing certain intangible assets include, but are not limited to future expected cash flows from acquired technology and acquired trademarks from a market participant perspective, useful lives and discount rates. Management’s estimates of fair value are based upon assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ from estimates. Acquisition -related
Concentrations of credit risk	U. Concentrations of credit risk Financial instruments that potentially expose the Company and its subsidiaries to concentrations of credit risk consist principally of cash and cash equivalents, short -term
Segment reporting	V. Segment reporting The Company identifies operating segments in accordance with ASC Topic 280, “Segment Reporting” as components of an entity for which discrete financial information is available and is regularly reviewed by the chief operating decision maker, or decision -making
Basic and diluted net income (loss) per share	W. Basic and diluted net income (loss) per share The Company computes basic income (loss) per share in accordance with ASC Topic 260, “Earnings per Share” by dividing the income (loss) attributable to ordinary shareholders by the weighted average number of ordinary shares outstanding during the year. Diluted income (loss) per share is computed by taking into account the potential dilution that could occur upon the exercise of share options and vesting of RSUs granted under share based compensation plans using the treasury stock method. Basic and diluted income (loss) per share was presented in conformity with the two class method for participating securities for the year ended December 31, 2021, 2020 and 2019, as a result of a dividend distribution. The potentially dilutive share options to purchase ordinary shares that were excluded from the computation amounted to 9,995,236, 31,728,133 and 29,276,607 for the years ended December 31, 2021, 2020 and 2019, respectively, because including them would have been anti dilutive. The Earn -Out -Out Public warrants and Private warrants, were excluded from the diluted income per share for the year ended December 31, 2021, as the inclusion would have been anti dilutive.
Recently issued accounting pronouncements	X. Recently issued accounting pronouncements As an “Emerging growth company,” the Jumpstart Our Business Startups Act (“JOBS Act”) allows the Company to delay adoption of new or revised accounting pronouncements applicable to public companies until such pronouncements are made applicable to private companies. The Company has elected to use this extended transition period under the JOBS Act. The adoption dates discussed below reflect this election. Recently adopted accounting pronouncements: • -08 ASU 2021 -08 The Company allocated the transaction price to each performance obligation based on the standalone selling price at the acquisition date. As a result of the amendments, it is expected that an acquirer will generally recognize and measure acquired contract assets and contract liabilities (deferred revenue) in a manner consistent with how the acquiree recognized and measured them in its preacquisition financial statements. In addition, as a result of the amendment, acquirer likely would subsequently recognize the same amount of revenue that the acquiree would have recognized if no business combination took place. The ASU will be effective for fiscal years beginning after December 15, 2022 and interim periods therein for public business entities. The Company early adopted the standard in 2021. Acquisitions of businesses assumed during the year ended December 31, 2021 were presented in conformity with the provisions of the standard. Recently issued accounting pronouncements not yet adopted: • -02 -of-use -type standard is effective for the annual periods beginning on or after January -USD • -13 ASU 2016 -13 • -12 -up
Certain comparative figures have been reclassified to conform to the current year presentation	Y. Certain comparative figures have been reclassified to conform to the current year presentation.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
Schedule of property and equipment	% Computers and software 12.5 – 33 Manufacturing equipment 7 Office furniture and equipment 7 – 15 Leasehold improvements *
Schedule of geographical areas	Year Ended December 31, 2021 2020 2019 EMEA $ 88,441 $ 65,807 $ 55,911 America 126,929 100,835 89,514 APAC 30,876 28,271 26,429 Total $ 246,246 $ 194,913 $ 171,854
Schedule of accounts receivable	December 31, 2021 December 31, 2020 Contract assets $ 8,567 $ 3,967 Contract liabilities, current 122,983 105,543 Contract liabilities, non-current $ 36,426 $ 33,439
Schedule of public and private warrants	Public Private Total Warrant liability assumed from the Business Combination $ 34,400 $ 34,045 $ 68,445 Change in fair value of warrant liability 800 (12,767 ) (11,967 ) Balance, December 31, 2021 $ 35,200 $ 21,278 $ 56,478
Schedule of expiration of the warrants	As of Number of private placement warrants 9,666,667 Exercise price $ Share price $ Expiration term (in years) 4.66 Volatility 44.8 Risk-free Rate 1.22 Dividend yield 0
Schedule of company issued equity and debt instrument.	Restricted Price Total Earn out shares assumed from the Business Combination $ 62,347 $ 117,675 $ 180,022 Change in fair value of warrant liability (17,635 ) (38,271 ) (55,906 ) Balance, December 31, 2021 $ 44,712 $ 79,404 $ 124,116
Schedule of intangible assets are amortized	Years Core technology 5 – 7 Trade name 4 Customer relationship 10

Business combination (Tables)

Business combination (Tables)	12 Months Ended
	Dec. 31, 2021
Business Combinations [Abstract]
Schedule of purchase price allocation	Amount Net assets $ (890 ) Technology 3,347 Customer relationship 177 Goodwill 17,366 Total $ 20,000
Schedule of components of identifiable intangible assets	Fair Value Useful Life US$ thousands In years Core technology 3,347 7 Customer relationship 177 10 Total identifiable intangible assets $ 3,524

Intangible assets, net (Tables)

Intangible assets, net (Tables)	12 Months Ended
	Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of definite-lived intangible assets	December 31, 2021 December 31, 2020 Original amounts: Core technology $ 10,411 $ 4,000 Trade name 3,900 3,900 Customer relationship 177 — 14,488 7,900 Accumulated amortization: Core technology 1,470 476 Trade name 1,788 813 Customer relationship 2 — Intangible assets, net 3,260 1,289 $ 11,228 $ 6,611
Schedule of future amortization expenses	2022 $ 2,655 2023 2,655 2024 1,843 2025 1,680 2026 and thereafter 2,395 $ 11,228

Prepaid Expenses and Other Cu_2

Prepaid Expenses and Other Current Assets (Tables)	12 Months Ended
	Dec. 31, 2021
Prepaid expenses and other current assets [Abstract]
Schedule of prepaid expenses and other current assets	December 31, 2021 December 31, 2020 Advances to suppliers $ 827 $ 163 Prepaid expenses 8,927 4,319 Government institutions 1,662 811 Other 1,402 2,146 $ 12,818 $ 7,439

Inventories (Tables)

Inventories (Tables)	12 Months Ended
	Dec. 31, 2021
Inventory Disclosure [Abstract]
Schedule of Inventories	December 31, 2021 December 31, 2020 Raw materials $ 4,742 $ 3,279 Finished goods 1,769 1,475 $ 6,511 $ 4,754

Property and Equipment, Net (Ta

Property and Equipment, Net (Tables)	12 Months Ended
	Dec. 31, 2021
Property, Plant and Equipment [Abstract]
Schedule of property and equipment, net	December 31, 2021 December 31, 2020 Manufacturing equipment $ 526 $ 509 Furniture and equipment 8,294 6,898 Leasehold improvements 6,637 6,430 Computers and software 22,735 18,931 38,192 32,768 Less – accumulated depreciation (21,436 ) (16,662 ) $ 16,756 $ 16,106

Other Accounts Payable and Ac_2

Other Accounts Payable and Accrued Expenses (Tables)	12 Months Ended
	Dec. 31, 2021
Payables and Accruals [Abstract]
Schedule of other accounts payable and accrued expenses	December 31, 2021 December 31, 2020 Governmental institution $ 2,372 $ 2,192 Employees and related expenses 29,725 28,098 Income tax payable 8,235 6,610 Accrued expenses 12,800 11,037 Phantom option units liability — 538 Advances from customers 695 559 Other 217 78 $ 54,044 $ 49,112

Commitments (Tables)

Commitments (Tables)	12 Months Ended
	Dec. 31, 2021
Commitments [Abstract]
Schedule of future minimum lease commitments under non-cancellable operating leases	US$ 2022 $ 4,890 2023 4,251 2024 5,417 2025 2,221 2026 and thereafter 1,722 $ 18,501

Shareholders' Equity (Deficie_2

Shareholders' Equity (Deficiency) and Redeemable Convertible Preferred Shares (Tables)	12 Months Ended
	Dec. 31, 2021
Stockholders' Equity Note [Abstract]
Schedule of fair value of options granted	Year ended December 31, 2021 2020 2019 Contractual period in years 10 10 10 Volatility 35.9% – 52.7% 45.1% – 50.2% 43.1% – 45.2% Risk free interest rate 1.3% – 1.4% 0.1% – 1.0% 2.2% – 2.8% Dividend yield —% – 5% 0% – 5% 0% – 5% Exercise price $ $2.385 – $5.190 $2.485 – $3.533 Fair value of Ordinary Share 5.41 – $8.270 $1.950 – $5.190 $2.032 – $3.533
Schedule of the company’s option activity	Number of Weighted- Weighted- Outstanding at December 31, 2020 30,834,504 $ 2.724 8.14 Granted 70,678 5.036 Exercised 2,626,573 2.661 Forfeited 2,790,712 2.874 Outstanding at December 31, 2021 25,487,897 $ 2.837 7.03 Exercisable at December 31, 2021 16,158,817 $ 2.643 6.45 Number of Weighted- average Weighted- Outstanding at December 31, 2019 27,377,797 $ 3.033 8.59 Granted 9,909,539 2.215 Exercised 693,101 2.238 Forfeited 5,759,731 3.485 Outstanding at December 31, 2020 30,834,504 2.724 8.14 Exercisable at December 31, 2020 13,828,828 2.618 5.70
Schedule of the company’s RSUs activity	December 31, December 31, Unvested at beginning of year 893,629 1,898,810 Granted 1,393,208 257,638 Vested* 178,254 805,716 Forfeited 65,059 457,103 Unvested, at end of year 2,043,524 893,629 __________ * 229,156 RSUs subject to deferral arrangements (“DSUs”) under the 2019 Restricted Share and Restricted Share Units Plan, that were vested as of Dec -31
Schedule of stock based compensation costs	Year Ended December 31, 2021 2020 2019 Cost of revenues $ 290 $ 304 $ 190 Research and development 1,076 1,145 1,212 Sales and marketing 2,332 2,298 2,969 General and administrative 2,782 3,524 8,388 $ 6,480 $ 7,271 $ 12,759

Net Income (Loss) Per Share (Ta

Net Income (Loss) Per Share (Tables)	12 Months Ended
	Dec. 31, 2021
Earnings Per Share [Abstract]
Schedule of computation of basic losses per share	Year Ended December 31, 2021 2020 2019 Numerator: Net income (loss) $ 71,396 $ 5,781 $ (1,876 ) Basic net income attributable to Preferred shareholders — 15,125 8,163 Basic net income attributable to Restricted sponsor shares 963 — — Basic net income (loss) attributable to Ordinary shareholders 70,433 (9,344 ) (10,039 ) Denominator: Weighted average number of Ordinary shares used in computing basic net income (loss) per share 144,002,394 123,696,624 121,560,817 Basic net income (loss) per share of Ordinary shareholders $ 0.49 $ (0.08 ) $ (0.08 ) Weighted average number of Ordinary shares used in computing diluted net income (loss) per share 161,538,579 123,696,624 121,560,817 Diluted net income (loss) per share of Ordinary shareholders $ 0.44 $ (0.08 ) $ (0.08 )

Revenues (Tables)

Revenues (Tables)	12 Months Ended
	Dec. 31, 2021
Revenue from Contract with Customer [Abstract]
Schedule of revenues	Year Ended December 31, 2021 2020 2019 Revenues from subscription services $ 120,889 $ 100,614 $ 81,505 Revenues from term-license 62,428 29,131 5,142 Total revenues from subscription 183,317 129,745 86,647 Revenues from perpetual license and other 34,169 42,136 59,175 Revenues from professional services 28,760 23,032 26,032 $ 246,246 $ 194,913 $ 171,854

Cost of revenues (Tables)

Cost of revenues (Tables)	12 Months Ended
	Dec. 31, 2021
Cost of revenues [Abstract]
Schedule of cost of revenues	Year Ended December 31, 2021 2020 2019 Materials and changes in inventories $ 10,316 $ 10,532 $ 7,638 Payroll and related expenses 19,754 17,019 14,272 Training expenses 3,885 2,713 5,338 Shipping expenses 1,548 1,543 1,784 Depreciation and Amortization 1,080 1,327 1,501 Inventory write-off 230 150 262 Travel 1,410 866 1,561 Other 4,334 3,729 3,467 $ 42,557 $ 37,879 $ 35,823
Schedule of cost of revenues by revenue type	Year Ended December 31, 2021 2020 2019 Cost of revenues from subscription services $ 9,369 $ 8,795 $ 6,585 Cost of term-license 2,299 1,709 189 Cost of revenues from perpetual license and 9,817 9,370 10,049 Cost of revenues from professional services 21,072 18,005 19,000 $ 42,557 $ 37,879 $ 35,823

Sales and marketing (Tables)

Sales and marketing (Tables)	12 Months Ended
	Dec. 31, 2021
Sales and marketing [Abstract]
Schedule of sales and marketing	Year Ended December 31, 2021 2020 2019 Payroll and related expenses $ 48,901 $ 39,991 $ 36,559 Sales commissions 10,312 8,246 6,624 Marketing and advertising 5,274 4,098 5,322 Travel and entertainment 2,279 1,276 4,939 Rent and maintenance 2,513 2,640 2,661 Depreciation and amortization 1,872 1,877 824 Vehicle costs 466 423 448 Professional consultants 1,349 808 1,889 Recruiting expenses 1,043 330 859 Other 2,380 1,616 1,485 $ 76,389 $ 61,305 $ 61,610

Research and development (Table

Research and development (Tables)	12 Months Ended
	Dec. 31, 2021
Research and development [Abstract]
Schedule of research and development	Year Ended December 31, 2021 2020 2019 Payroll and related expenses $ 53,683 $ 45,716 39,142 Rent and maintenance 1,851 2,117 1,721 Subcontractors and projects 3,482 2,676 2,398 Travel and entertainment 185 20 314 Vehicle costs 232 270 355 Recruiting expenses 178 127 222 Depreciation and amortization 2,100 1,813 1,135 Other 3,830 1,638 1,286 $ 65,541 $ 54,377 $ 46,573

General and administrative (Tab

General and administrative (Tables)	12 Months Ended
	Dec. 31, 2021
General and Administrative [Abstract]
Schedule of general and administrative	Year Ended December 31, 2021 2020 2019 Payroll and related expenses $ 19,366 $ 18,460 16,386 Professional fees 4,307 4,274 2,040 Vehicle costs 469 328 263 Rent and maintenance 1,559 2,147 2,071 Travel and entertainment 249 262 425 Refreshments, gifts and donations 525 778 645 Doubtful accounts and bad debts 676 606 266 Recruiting expenses 727 330 386 Depreciation 1,955 978 484 Issuance costs 11,835 — — Other 6,269 3,971 6,402 $ 47,937 $ 32,134 $ 29,368

Taxes on income (Tables)

Taxes on income (Tables)	12 Months Ended
	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Schedule of the deferred tax liabilities and assets	December 31, 2021 December 31, 2020 Deferred tax assets: Deferred research and development cost $ 3,556 $ 4,970 Employee related liabilities 842 906 Intangible assets 1,125 1,304 Goodwill 2,773 1,354 Deferred revenues 1,765 1,164 Issuance costs 1,347 — Other 1,068 431 Total deferred tax assets 12,476 10,129 Deferred tax liabilities: Deferred costs 1,324 1,242 Intangible assets 545 771 Goodwill 180 68 Property and equipment 438 455 Derivative instruments 79 208 Other 110 13 Total deferred tax liabilities 2,676 2,757 Total deferred tax assets, net $ 9,800 $ 7,372
Schedule of income before income tax expense to the reported amount	Year Ended December 31, 2021 2020 2019 Income before income taxes expense, as reported in the consolidated statements of operations $ 82,305 $ 11,397 $ 1,415 Statutory tax rate in Israel 23 % 23 % 23 % Theoretical taxes on income 18,930 2,621 325 Foreign subsidiaries taxed at different tax rates 167 81 76 Preferred tax rates in Israel (7,598 ) (72 ) 937 Revaluation of liability instruments (8,145 ) — — Non-deductible expense 1,363 1,501 2,293 Taxes in respect of prior years (125 ) 78 (283 ) Intercompany transfer of intangible assets — 1,324 — Tax on dividend distributed from trapped earnings 7,068 — — Other (751 ) 83 (57 ) Actual income tax expense $ 10,909 $ 5,616 $ 3,291
Schedule of income tax expense	Year Ended December 31, 2021 2020 2019 Domestic $ 71,434 $ 4,348 $ (3,920 ) Foreign 10,871 7,049 5,335 $ 82,305 $ 11,397 $ 1,415
Schedule of income tax expenses allocated to continuing operations	Year Ended December 31, 2021 2020 2019 Current: Israel $ 9,665 $ 4,549 $ 3,950 Foreign 2,882 3,885 1,008 Total current tax expense: 12,547 8,434 4,958 Deferred: Israel (10 ) (3,729 ) (1,897 ) Foreign (1,628 ) 911 230 Total deferred tax benefit (1,638 ) (2,818 ) (1,667 ) Total income tax expense $ 10,909 $ 5,616 $ 3,291
Schedule of the total amounts of unrecognized tax benefits	December 31, 2021 December 31, 2020 Unrecognized tax benefits, beginning of year $ 2,007 $ 1,689 Decreases in tax positions for prior years — (388 ) Increases in tax positions for current year 1,231 706 Unrecognized tax benefits, end of year $ 3,238 $ 2,007

Financial income, net (Tables)

Financial income, net (Tables)	12 Months Ended
	Dec. 31, 2021
Financial income, net [Abstract]
Schedule of financial income, net	Year Ended December 31, 2021 2020 2019 Financial income: Interest on deposits $ 847 $ 2,710 $ 3,475 Foreign currency translation differences $ 51 780 380 Revaluation of liability instruments $ 67,873 — — Other $ 276 112 — Financial expenses: Bank charges $ (166 ) (197 ) (222 ) Changes in exchange rates $ (245 ) (1,226 ) (568 ) Other $ (153 ) — (130 ) $ 68,483 $ 2,179 $ 2,935

Transactions and Balances Wit_2

Transactions and Balances With Related Parties (Tables)	12 Months Ended
	Dec. 31, 2021
Related Party Transactions [Abstract]
Schedule of transactions with SUN corporation	Year Ended December 31, 2021 December 31, 2020 December 31, 2019 Revenues 3,678 1,865 3,662
Schedule of balances with SUN corporation	December 31, 2021 December 31, 2020 Trade receivables 214 — Trade payables — (154 )

General (Details)

General (Details) - USD ($) $ in Thousands	Nov. 11, 2021	Feb. 28, 2020
General (Details) [Line Items]
Total consideration	$ 20,000
BlackBag [Member]
General (Details) [Line Items]
Total base consideration		$ 33,362
Business Combination [Member] | BlackBag [Member]
General (Details) [Line Items]
Acquisition shares percentage		100.00%

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Jan. 01, 2022
Summary of Significant Accounting Policies (Details) [Line Items]
Deferred revenue		$ 138,982	$ 159,409
Recognized revenue	$ 97,823	61,964
Commission expenses	10,700	8,400	6,800
Advertising expenses	$ 5,274	4,098	$ 5,315
Tax benefit, percentage	50.00%
Public warrants (in Shares)	20,000,000
Private warrants (in Shares)	9,666,667
Price per share (in Dollars per share)	$ 11.5
Price per warrant (in Dollars per share)	0.01
Exceeds per share (in Dollars per share)	$ 18
Restricted sponsor shares, description	7,500,000 Ordinary Shares issued to the Sponsor, out of a total of 13,500,000 shares, are Restricted Shares and will vest in 3 tranches of 3,000,000, 3,000,000 and 1,500,000, upon achievement of the of the triggering events (as defined in the business combination agreement); if at any time during the Price Adjustment Period the price of Cellebrite Ordinary Shares will be greater than or equal to $12.50, $15.00 and $30.00, respectively,
Ordinary shares, description	Holders of the Company’s Ordinary Shares and vested Restricted Share Units, in each case as of immediately prior to the effective time, are eligible to receive up to 15,000,000 Ordinary Shares that will vest in 3 tranches of 5,000,000 upon achievement of the of the triggering events (if at any time during the Price Adjustment Period the price of Cellebrite Ordinary Shares will be greater than or equal to $12.50, $15.00 and $30.00, respectively, over any twenty trading days within any thirty trading day period.
Net of tax	$ 577	1,521
Forward contracts	15,623
Instruments assets	$ 964	$ 2,016
Operating segment	1
Reporting unit	1
Determined operates segment	1
Reportable segment	1
Purchase ordinary shares (in Shares)	9,995,236	31,728,133	29,276,607
Subsequent Event [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Lease liabilities				$ 16,400
Minimum [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Dividend yield, percentage	0.00%
Historical rate, percentage	0.00%
Maximum [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Dividend yield, percentage	5.00%
Historical rate, percentage	5.00%

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details) - Schedule of property and equipment	Dec. 31, 2021USD ($)
Manufacturing equipment [Member]
Summary of Significant Accounting Policies (Details) - Schedule of property and equipment [Line Items]
Property and equipment percentage	$ 7
Leasehold improvements [Member]
Summary of Significant Accounting Policies (Details) - Schedule of property and equipment [Line Items]
Property and equipment percentage
Minimum [Member] | Computers and software [Member]
Summary of Significant Accounting Policies (Details) - Schedule of property and equipment [Line Items]
Property and equipment percentage	12.5
Minimum [Member] | Office furniture and equipment [Member]
Summary of Significant Accounting Policies (Details) - Schedule of property and equipment [Line Items]
Property and equipment percentage	7
Maximum [Member] | Computers and software [Member]
Summary of Significant Accounting Policies (Details) - Schedule of property and equipment [Line Items]
Property and equipment percentage	33
Maximum [Member] | Office furniture and equipment [Member]
Summary of Significant Accounting Policies (Details) - Schedule of property and equipment [Line Items]
Property and equipment percentage	$ 15

Summary of Significant Accoun_5

Summary of Significant Accounting Policies (Details) - Schedule of geographical areas - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Segment Reporting Information [Line Items]
Disaggregated revenue	$ 246,246	$ 194,913	$ 171,854
EMEA [Member]
Segment Reporting Information [Line Items]
Disaggregated revenue	88,441	65,807	55,911
America [Member]
Segment Reporting Information [Line Items]
Disaggregated revenue	126,929	100,835	89,514
APAC [Member]
Segment Reporting Information [Line Items]
Disaggregated revenue	$ 30,876	$ 28,271	$ 26,429

Summary of Significant Accoun_6

Summary of Significant Accounting Policies (Details) - Schedule of accounts receivable - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Schedule of accounts receivable [Abstract]
Contract assets	$ 8,567	$ 3,967
Contract liabilities, current	122,983	105,543
Contract liabilities, non-current	$ 36,426	$ 33,439

Summary of Significant Accoun_7

Summary of Significant Accounting Policies (Details) - Schedule of public and private warrants $ in Thousands	12 Months Ended
	Dec. 31, 2021USD ($)
Public Warrants [Member]
Summary of Significant Accounting Policies (Details) - Schedule of public and private warrants [Line Items]
Warrant liability assumed from the Business Combination	$ 34,400
Change in fair value of warrant liability	800
Balance, December 31, 2021	35,200
Private Placement Warrants [Member]
Summary of Significant Accounting Policies (Details) - Schedule of public and private warrants [Line Items]
Warrant liability assumed from the Business Combination	34,045
Change in fair value of warrant liability	(12,767)
Balance, December 31, 2021	21,278
Total Derivative Warrant Liability [Member]
Summary of Significant Accounting Policies (Details) - Schedule of public and private warrants [Line Items]
Warrant liability assumed from the Business Combination	68,445
Change in fair value of warrant liability	(11,967)
Balance, December 31, 2021	$ 56,478

Summary of Significant Accoun_8

Summary of Significant Accounting Policies (Details) - Schedule of expiration of the warrants $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2021USD ($)$ / shares
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]
Number of private placement warrants (in Dollars) | $	$ 9,666,667
Exercise price (in Dollars per share)	$ 11.5
Share price (in Dollars per share)	$ 8.02
Expiration term (in years)	4 years 7 months 28 days
Volatility	44.80%
Risk-free Rate	1.22%
Minimum [Member]
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]
Dividend yield	0.00%
Maximum [Member]
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]
Dividend yield	5.00%

Summary of Significant Accoun_9

Summary of Significant Accounting Policies (Details) - Schedule of company issued equity and debt instrument. $ in Thousands	12 Months Ended
	Dec. 31, 2021USD ($)
Summary of Significant Accounting Policies (Details) - Schedule of company issued equity and debt instrument. [Line Items]
Earn out shares assumed from the Business Combination	$ 180,022
Change in fair value of warrant liability	(55,906)
Balance, December 31, 2021	124,116
Restricted Sponsor Shares [Member]
Summary of Significant Accounting Policies (Details) - Schedule of company issued equity and debt instrument. [Line Items]
Earn out shares assumed from the Business Combination	62,347
Change in fair value of warrant liability	(17,635)
Balance, December 31, 2021	44,712
Price Adjustment Shares [Member]
Summary of Significant Accounting Policies (Details) - Schedule of company issued equity and debt instrument. [Line Items]
Earn out shares assumed from the Business Combination	117,675
Change in fair value of warrant liability	(38,271)
Balance, December 31, 2021	$ 79,404

Summary of Significant Accou_10

Summary of Significant Accounting Policies (Details) - Schedule of intangible assets are amortized	12 Months Ended
	Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]
Trade name	4 years
Customer relationship	10 years
Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Core technology	5 years
Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Core technology	7 years

Business combination (Details)

Business combination (Details) - USD ($) $ / shares in Units, $ in Thousands	Nov. 11, 2021	Apr. 08, 2021	Feb. 27, 2020	Dec. 31, 2021
Business combination (Details) [Line Items]
Merger Initial Dividend		$ 21,300
Merger additional dividend		78,700
Share value		$ 10
PIPE Investor [Member]
Business combination (Details) [Line Items]
Purchase price (in Dollars per share)		$ 10
Number of shares (in Shares)		30,000,000
Aggregate purchase price		$ 300,000
Shares converted (in Shares)		30,000,000
BlackBag Technologies Inc [Member]
Business combination (Details) [Line Items]
Acquisition percentage			100.00%
Total consideration			$ 33,362
Cash consideration paid			15,362
Consideration paid in installments			18,000
Business Combination, Contingent Consideration Arrangements, Change in Range of Outcomes, Contingent Consideration, Liability, Value, High			$ 6,000
Consideration in installment, description			$6,000 each year in the first, second and third anniversary of the closing.
Employee retention amount			$ 13,000
Acquisition expenses			1,848
Trade name			4,000
Core technology			3,900
Goodwill			9,463
Amortization costs			1,289
Intangible assets			$ 1,546
Digital Clues LTD. [Member]
Business combination (Details) [Line Items]
Total consideration	$ 20,000
Amortization expenses				$ 67
Transaction costs				$ 267
Trade Names [Member] | BlackBag Technologies Inc [Member]
Business combination (Details) [Line Items]
Useful life of finite-lived			4 years
Core Technology [Member] | BlackBag Technologies Inc [Member]
Business combination (Details) [Line Items]
Useful life of finite-lived			7 years

Business combination (Details)

Business combination (Details) - Schedule of purchase price allocation $ in Thousands	Dec. 31, 2021USD ($)
Schedule of purchase price allocation [Abstract]
Net assets	$ (890)
Technology	3,347
Customer relationship	177
Goodwill	17,366
Total	$ 20,000

Business combination (Details_2

Business combination (Details) - Schedule of components of identifiable intangible assets $ in Thousands	12 Months Ended
	Dec. 31, 2021USD ($)
Business combination (Details) - Schedule of components of identifiable intangible assets [Line Items]
Total identifiable intangible assets	$ 3,524
Core Technology [Member]
Business combination (Details) - Schedule of components of identifiable intangible assets [Line Items]
Total identifiable intangible assets	$ 3,347
Useful Life	7 years
Customer Relationship [Member]
Business combination (Details) - Schedule of components of identifiable intangible assets [Line Items]
Total identifiable intangible assets	$ 177
Useful Life	10 years

Intangible assets, net (Details

Intangible assets, net (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization expense amounted	$ 1,971	$ 1,289	$ 0

Intangible assets, net (Detai_2

Intangible assets, net (Details) - Schedule of definite-lived intangible assets - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Original amounts:
Intangible assets, gross	$ 14,488	$ 7,900
Accumulated amortization:
Intangible assets, net total	11,228	6,611
Core technology [Member]
Original amounts:
Intangible assets, gross	10,411	4,000
Accumulated amortization:
Intangible assets, net total	1,470	476
Trade name [Member]
Original amounts:
Intangible assets, gross	3,900	3,900
Accumulated amortization:
Intangible assets, net total	1,788	813
Customer relationship [Member]
Original amounts:
Intangible assets, gross	177
Accumulated amortization:
Intangible assets, net total	2
Intangible assets, net [Member]
Accumulated amortization:
Intangible assets, net total	$ 3,260	$ 1,289

Intangible assets, net (Detai_3

Intangible assets, net (Details) - Schedule of future amortization expenses $ in Thousands	Dec. 31, 2021USD ($)
Schedule of future amortization expenses [Abstract]
2022	$ 2,655
2023	2,655
2024	1,843
2025	1,680
2026 and thereafter	2,395
Total	$ 11,228

Short-Term Deposits (Details)

Short-Term Deposits (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Short-Term Deposits (Details) [Line Items]
Short-term deposits (in Dollars)	$ 35,592	$ 108,928
Minimum [Member]
Short-Term Deposits (Details) [Line Items]
Interest rates	0.10%	0.27%
Maximum [Member]
Short-Term Deposits (Details) [Line Items]
Interest rates	1.55%	2.47%

Prepaid Expenses and Other Cu_3

Prepaid Expenses and Other Current Assets (Details) - Schedule of prepaid expenses and other current assets - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Schedule of prepaid expenses and other current assets [Abstract]
Advances to suppliers	$ 827	$ 163
Prepaid expenses	8,927	4,319
Government institutions	1,662	811
Other	1,402	2,146
Total	$ 12,818	$ 7,439

Inventories (Details) - Schedul

Inventories (Details) - Schedule of Inventories - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Schedule of Inventories [Abstract]
Raw materials	$ 4,742	$ 3,279
Finished goods	1,769	1,475
Total	$ 6,511	$ 4,754

Property and Equipment, Net (De

Property and Equipment, Net (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Property, Plant and Equipment [Abstract]
Depreciation expenses	$ 5,036	$ 4,464	$ 3,587

Property and Equipment, Net (_2

Property and Equipment, Net (Details) - Schedule of property and equipment, net - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 38,192	$ 32,768
Less – accumulated depreciation	(21,436)	(16,662)
Property and equipment, net	16,756	16,106
Manufacturing equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	526	509
Furniture and equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	8,294	6,898
Leasehold improvements [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	6,637	6,430
Computers and software [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 22,735	$ 18,931

Other Accounts Payable and Ac_3

Other Accounts Payable and Accrued Expenses (Details) - Schedule of other accounts payable and accrued expenses - Other Accounts Payable and Accrued Expenses [Member] - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Other Accounts Payable and Accrued Expenses (Details) - Schedule of other accounts payable and accrued expenses [Line Items]
Governmental institution	$ 2,372	$ 2,192
Employees and related expenses	29,725	28,098
Income tax payable	8,235	6,610
Accrued expenses	12,800	11,037
Phantom option units liability		538
Advances from customers	695	559
Other	217	78
Total	$ 54,044	$ 49,112

Liability for Employees Sever_2

Liability for Employees Severance Benefits (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Retirement Benefits [Abstract]
Severance pay expenses amounted	$ 4,067	$ 3,340	$ 3,476
Matching contributions, percentage	6.00%
Contributions, description	For the year ended December 31, 2021 and 2020, the Company made 401(k) plan contributions of approximately $1,455, $877 and $774 , respectively.

Commitments (Details) - Schedul

Commitments (Details) - Schedule of future minimum lease commitments under non-cancellable operating leases $ in Thousands	Dec. 31, 2021USD ($)
Schedule of future minimum lease commitments under non-cancellable operating leases [Abstract]
2022	$ 4,890
2023	4,251
2024	5,417
2025	2,221
2026 and thereafter	1,722
Total	$ 18,501

Shareholders' Equity (Deficie_3

Shareholders' Equity (Deficiency) and Redeemable Convertible Preferred Shares (Details) $ / shares in Units, $ in Thousands	1 Months Ended		12 Months Ended
	Aug. 30, 2021	Jul. 17, 2019USD ($)$ / sharesshares	Dec. 31, 2021USD ($)$ / sharesshares	Dec. 31, 2020USD ($)$ / sharesshares	Dec. 31, 2019shares	Dec. 31, 2021ILS (₪)shares	Dec. 31, 2020ILS (₪)shares
Shareholders' Equity (Deficiency) and Redeemable Convertible Preferred Shares (Details) [Line Items]
Ordinary shares par value (in New Shekels) | ₪						₪ 0.00001	₪ 0.00001
Ordinary shares authorized			3,454,112,863	3,454,112,863		3,454,112,863	3,454,112,863
Convertible preferred shares issued		39,779,261
Convertible preferred shares per share (in Dollars per share) | $ / shares		$ 2.765
Total consideration (in Dollars) | $		$ 101,205
Invested amount (in Dollars) | $		$ 110,000
Outstanding ordinary and preferred shares percentage		24.40%
Compensation amount (in Dollars) | $		$ 4,034
Acquired shares				43,540	295,000
Authorized but unissued shares		5,756,855
Maximum aggregate number of shares			28,075,309
Aggregate number of Shares			1,871,687
Shares outstanding percentage			1.00%
RSU outstanding			27,276,343			27,276,343
Weighted average fair values at grant date of options granted (in Dollars per share) | $ / shares			$ 5.04	$ 0.74
Total intrinsic value of options exercised (in Dollars) | $			$ 8,547	$ 2,171
Aggregate intrinsic value of the outstanding options			25,440,041	29,414,990
Remaining outstanding options			70,678	143,939
Intrinsic value considered			0	0
Weighted average fair value at grant date of RSUs granted (in Dollars per share) | $ / shares			$ 1.95	$ 8.27
Total fair value of shares vested (in Dollars) | $			$ 927	$ 4,327
Unrecognized compensation expense (in Dollars) | $			$ 20,316
Weighted average period			3 years 7 months 6 days
Stock based compensation to employees			4,559,059
Minimum [Member]
Shareholders' Equity (Deficiency) and Redeemable Convertible Preferred Shares (Details) [Line Items]
Reverse stock split	1
Maximum [Member]
Shareholders' Equity (Deficiency) and Redeemable Convertible Preferred Shares (Details) [Line Items]
Reverse stock split	1.0422

Shareholders' Equity (Deficie_4

Shareholders' Equity (Deficiency) and Redeemable Convertible Preferred Shares (Details) - Schedule of fair value of options granted - $ / shares	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Shareholders' Equity (Deficiency) and Redeemable Convertible Preferred Shares (Details) - Schedule of fair value of options granted [Line Items]
Contractual period in years	10 years	10 years	10 years
Dividend yield	5.00%
Exercise price (in Dollars per share)	$ 2.643	$ 2.618
Minimum [Member]
Shareholders' Equity (Deficiency) and Redeemable Convertible Preferred Shares (Details) - Schedule of fair value of options granted [Line Items]
Volatility	35.90%	45.10%	43.10%
Risk free interest rate	1.30%	0.10%	2.20%
Dividend yield		0.00%	0.00%
Exercise price (in Dollars per share)	$ 0	$ 2.385	$ 2.485
Fair value of Ordinary Share (in Dollars per share)	$ 5.41	$ 1.95	$ 2.032
Maximum [Member]
Shareholders' Equity (Deficiency) and Redeemable Convertible Preferred Shares (Details) - Schedule of fair value of options granted [Line Items]
Volatility	52.70%	50.20%	45.20%
Risk free interest rate	1.40%	1.00%	2.80%
Dividend yield		5.00%	5.00%
Exercise price (in Dollars per share)	$ 8.27	$ 5.19	$ 3.533
Fair value of Ordinary Share (in Dollars per share)	$ 8.27	$ 5.19	$ 3.533

Shareholders' Equity (Deficie_5

Shareholders' Equity (Deficiency) and Redeemable Convertible Preferred Shares (Details) - Schedule of the company’s option activity - $ / shares	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Schedule of the company’s option activity [Abstract]
Number of options, beginning balance	30,834,504	27,377,797
Weighted- average exercise price, beginning balance	$ 2.724	$ 3.033
Weighted- average remaining contractual term (in years), beginning balance	8 years 1 month 20 days	8 years 7 months 2 days
Number of options, Granted	70,678	9,909,539
Weighted- average exercise price, Granted	$ 5.036	$ 2.215
Number of options, exercised	2,626,573	693,101
Weighted- average exercise price, exercised	$ 2.661	$ 2.238
Number of options, forfeited	2,790,712	5,759,731
Weighted- average exercise price, forfeited	$ 2.874	$ 3.485
Number of options, ending balance	25,487,897	30,834,504
Weighted- average exercise price, ending balance	$ 2.837	$ 2.724
Weighted- average remaining contractual term (in years), ending balance	7 years 10 days	8 years 1 month 20 days
Number of options, exercisable	16,158,817	13,828,828
Weighted- average exercise price, exercisable	$ 2.643	$ 2.618
Weighted- average remaining contractual term (in years), exercisable	6 years 5 months 12 days	5 years 8 months 12 days

Shareholders' Equity (Deficie_6

Shareholders' Equity (Deficiency) and Redeemable Convertible Preferred Shares (Details) - Schedule of the company’s RSUs activity - shares		12 Months Ended
		Dec. 31, 2021	Dec. 31, 2020
Schedule of the company’s RSUs activity [Abstract]
Unvested at beginning of year		893,629	1,898,810
Granted		1,393,208	257,638
Vested	[1]	178,254	805,716
Forfeited		65,059	457,103
Unvested, at end of year		2,043,524	893,629
[1]	229,156 RSUs subject to deferral arrangements (“DSUs”) under the 2019 Restricted Share and Restricted Share Units Plan, that were vested as of Dec-31, 2020, and additional 43,356 DSUs that were vested in 2021 are not included in the count of shares, as according to that plan, upon their vesting they remain as a Share Unit and not converted into shares.

Shareholders' Equity (Deficie_7

Shareholders' Equity (Deficiency) and Redeemable Convertible Preferred Shares (Details) - Schedule of stock based compensation costs - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Schedule of stock based compensation costs [Abstract]
Cost of revenues	$ 290	$ 304	$ 190
Research and development	1,076	1,145	1,212
Sales and marketing	2,332	2,298	2,969
General and administrative	2,782	3,524	8,388
Total	$ 6,480	$ 7,271	$ 12,759

Net Income (Loss) Per Share (De

Net Income (Loss) Per Share (Details) - Schedule of computation of basic losses per share - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Numerator:
Net income (loss) (in Dollars)	$ 71,396	$ 5,781	$ (1,876)
Basic net income attributable to Preferred shareholders		15,125	8,163
Basic net income attributable to Restricted sponsor shares	963
Basic net income (loss) attributable to Ordinary shareholders	70,433	(9,344)	(10,039)
Denominator:
Weighted average number of Ordinary shares used in computing basic net income (loss) per share	144,002,394	123,696,624	121,560,817
Basic net income (loss) per share of Ordinary shareholders (in Dollars per share)	$ 0.49	$ (0.08)	$ (0.08)
Weighted average number of Ordinary shares used in computing diluted net income (loss) per share	161,538,579	123,696,624	121,560,817
Diluted net income (loss) per share of Ordinary shareholders (in Dollars per share)	$ 0.44	$ (0.08)	$ (0.08)

Revenues (Details)

Revenues (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Revenue from Contract with Customer [Abstract]
Related party revenues	$ 3,678	$ 1,865	$ 3,662

Revenues (Details) - Schedule o

Revenues (Details) - Schedule of revenues - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Schedule of revenues [Abstract]
Revenues from subscription services	$ 120,889	$ 100,614	$ 81,505
Revenues from term-license	62,428	29,131	5,142
Total revenues from subscription	183,317	129,745	86,647
Revenues from perpetual license and other	34,169	42,136	59,175
Revenues from professional services	28,760	23,032	26,032
Revenues	$ 246,246	$ 194,913	$ 171,854

Cost of revenues (Details) - Sc

Cost of revenues (Details) - Schedule of cost of revenues - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Schedule of cost of revenues [Abstract]
Materials and changes in inventories	$ 10,316	$ 10,532	$ 7,638
Payroll and related expenses	19,754	17,019	14,272
Training expenses	3,885	2,713	5,338
Shipping expenses	1,548	1,543	1,784
Depreciation and Amortization	1,080	1,327	1,501
Inventory write-off	230	150	262
Travel	1,410	866	1,561
Other	4,334	3,729	3,467
Total	$ 42,557	$ 37,879	$ 35,823

Cost of revenues (Details) - _2

Cost of revenues (Details) - Schedule of cost of revenues by revenue type - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Schedule of cost of revenues by revenue type [Abstract]
Cost of revenues from subscription services	$ 9,369	$ 8,795	$ 6,585
Cost of term-license	2,299	1,709	189
Cost of revenues from perpetual license and other	9,817	9,370	10,049
Cost of revenues from professional services	21,072	18,005	19,000
Total	$ 42,557	$ 37,879	$ 35,823

Sales and marketing (Details) -

Sales and marketing (Details) - Schedule of sales and marketing - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Schedule of sales and marketing [Abstract]
Payroll and related expenses	$ 48,901	$ 39,991	$ 36,559
Sales commissions	10,312	8,246	6,624
Marketing and advertising	5,274	4,098	5,322
Travel and entertainment	2,279	1,276	4,939
Rent and maintenance	2,513	2,640	2,661
Depreciation and amortization	1,872	1,877	824
Vehicle costs	466	423	448
Professional consultants	1,349	808	1,889
Recruiting expenses	1,043	330	859
Other	2,380	1,616	1,485
Total	$ 76,389	$ 61,305	$ 61,610

Research and development (Detai

Research and development (Details) - Schedule of research and development - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Schedule of research and development [Abstract]
Payroll and related expenses	$ 53,683	$ 45,716	$ 39,142
Rent and maintenance	1,851	2,117	1,721
Subcontractors and projects	3,482	2,676	2,398
Travel and entertainment	185	20	314
Vehicle costs	232	270	355
Recruiting expenses	178	127	222
Depreciation and amortization	2,100	1,813	1,135
Other	3,830	1,638	1,286
Total	$ 65,541	$ 54,377	$ 46,573

General and administrative (Det

General and administrative (Details) - Schedule of general and administrative - General and Administrative [Member] - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
General and administrative (Details) - Schedule of general and administrative [Line Items]
Payroll and related expenses	$ 19,366	$ 18,460	$ 16,386
Professional fees	4,307	4,274	2,040
Vehicle costs	469	328	263
Rent and maintenance	1,559	2,147	2,071
Travel and entertainment	249	262	425
Refreshments, gifts and donations	525	778	645
Doubtful accounts and bad debts	676	606	266
Recruiting expenses	727	330	386
Depreciation	1,955	978	484
Issuance costs	11,835
Other	6,269	3,971	6,402
General and administrative total	$ 47,937	$ 32,134	$ 29,368

Taxes on income (Details)

Taxes on income (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Aug. 30, 2021
Taxes on income (Details) [Line Items]
Effective tax rate	50.00%
Income taxable at tax rate	0.00%
Trapped earnings (in Dollars)	$ 71,000
Related income tax expense (in Dollars)	$ 7,000
Beneficiary corporate tax rate	6.00%
Industrial plants over	5 years
Trapped earning distributed (in Dollars)				$ 71,000
Taxed at reduced tax rate	12.00%
Reduced tax rate	7.50%
Income taxes on non-Israeli subsidiaries	the Company’s U.S. subsidiary is subject to combined federal and state income taxes of 26% and the subsidiaries in Germany and Singapore are subject to corporation tax at a rate of approximately 33% and 17% respectively. As of December 31, 2021, the Company had approximately $25,768 undistributed earnings of its subsidiaries for which a deferred tax liability of approximately $4,125 was not recognized.
Uncertain tax positions amounted (in Dollars)	$ 92	$ 25	$ 51
Total accrued interest (in Dollars)	$ 168	$ 76
Israel [Member]
Taxes on income (Details) [Line Items]
Effective tax rate	23.00%	23.00%	23.00%
Minimum [Member]
Taxes on income (Details) [Line Items]
Beneficial tax rates	0.00%
Corporate tax rate	40.00%
Maximum [Member]
Taxes on income (Details) [Line Items]
Beneficial tax rates	10.00%
Corporate tax rate	70.00%

Taxes on income (Details) - Sch

Taxes on income (Details) - Schedule of the deferred tax liabilities and assets - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Deferred tax assets:
Deferred research and development cost	$ 3,556	$ 4,970
Employee related liabilities	842	906
Intangible assets	1,125	1,304
Goodwill	2,773	1,354
Deferred revenues	1,765	1,164
Issuance costs	1,347
Other	1,068	431
Total deferred tax assets	12,476	10,129
Deferred tax liabilities:
Deferred costs	1,324	1,242
Intangible assets	545	771
Goodwill	180	68
Property and equipment	438	455
Derivative instruments	79	208
Other	110	13
Total deferred tax liabilities	2,676	2,757
Total deferred tax assets, net	$ 9,800	$ 7,372

Taxes on income (Details) - S_2

Taxes on income (Details) - Schedule of income before income tax expense to the reported amount - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Schedule of income before income tax expense to the reported amount [Abstract]
Income before income taxes expense, as reported in the consolidated statements of operations	$ 82,305	$ 11,397	$ 1,415
Statutory tax rate in Israel	23.00%	23.00%	23.00%
Theoretical taxes on income	$ 18,930	$ 2,621	$ 325
Foreign subsidiaries taxed at different tax rates	167	81	76
Preferred tax rates in Israel	(7,598)	(72)	937
Revaluation of liability instruments	(8,145)
Non-deductible expense	1,363	1,501	2,293
Taxes in respect of prior years	(125)	78	(283)
Intercompany transfer of intangible assets		1,324
Tax on dividend distributed from trapped earnings	7,068
Other	(751)	83	(57)
Actual income tax expense	$ 10,909	$ 5,616	$ 3,291

Taxes on income (Details) - S_3

Taxes on income (Details) - Schedule of income tax expense - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Schedule of income tax expense [Abstract]
Domestic	$ 71,434	$ 4,348	$ (3,920)
Foreign	10,871	7,049	5,335
Total	$ 82,305	$ 11,397	$ 1,415

Taxes on income (Details) - S_4

Taxes on income (Details) - Schedule of income tax expenses allocated to continuing operations - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Current:
Israel	$ 9,665	$ 4,549	$ 3,950
Foreign	2,882	3,885	1,008
Total current tax expense:	12,547	8,434	4,958
Deferred:
Israel	(10)	(3,729)	(1,897)
Foreign	(1,628)	911	230
Total deferred tax benefit	(1,638)	(2,818)	(1,667)
Total income tax expense	$ 10,909	$ 5,616	$ 3,291

Taxes on income (Details) - S_5

Taxes on income (Details) - Schedule of the total amounts of unrecognized tax benefits - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Schedule of the total amounts of unrecognized tax benefits [Abstract]
Unrecognized tax benefits, beginning of year	$ 2,007	$ 1,689
Decreases in tax positions for prior years		(388)
Increases in tax positions for current year	1,231	706
Unrecognized tax benefits, end of year	$ 3,238	$ 2,007

Financial income, net (Details)

Financial income, net (Details) - Schedule of financial income, net - Financial income, Net [Member] - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Financial income:
Interest on deposits	$ 847	$ 2,710	$ 3,475
Foreign currency translation differences	51	780	380
Revaluation of liability instruments	67,873
Other	276	112
Financial expenses:
Bank charges	(166)	(197)	(222)
Changes in exchange rates	(245)	(1,226)	(568)
Other	(153)		(130)
Total	$ 68,483	$ 2,179	$ 2,935

Dividend distribution (Details)

Dividend distribution (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Dividend distribution (Details) [Line Items]
Distributed dividend	$ 100,000	$ 10,000
Minimum [Member]
Dividend distribution (Details) [Line Items]
Tax shareholder percentage	5.00%
Maximum [Member]
Dividend distribution (Details) [Line Items]
Tax shareholder percentage	25.00%

Transactions and Balances Wit_3

Transactions and Balances With Related Parties (Details) - Schedule of transactions with SUN corporation - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Transactions With SUN Corporation [Member]
Condensed Statement of Income Captions [Line Items]
Revenues	$ 3,678,000	$ 1,865,000	$ 3,662,000

Transactions and Balances Wit_4

Transactions and Balances With Related Parties (Details) - Schedule of balances with SUN corporation - Balances With SUN Corporation [Member] - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Transactions and Balances With Related Parties (Details) - Schedule of balances with SUN corporation [Line Items]
Trade receivables	$ 214
Trade payables		$ (154)